<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10767883</article-id>
    <article-id pub-id-type="pmid">37953365</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkad1043</article-id>
    <article-id pub-id-type="publisher-id">gkad1043</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MAJIQlopedia: an encyclopedia of RNA splicing variations in human tissues and cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9945-8123</contrib-id>
        <name>
          <surname>Quesnel-Vallières</surname>
          <given-names>Mathieu</given-names>
        </name>
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Biochemistry and Biophysics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jewell</surname>
          <given-names>San</given-names>
        </name>
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0120-8079</contrib-id>
        <name>
          <surname>Lynch</surname>
          <given-names>Kristen W</given-names>
        </name>
        <aff><institution>Department of Biochemistry and Biophysics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2739-2206</contrib-id>
        <name>
          <surname>Thomas-Tikhonenko</surname>
          <given-names>Andrei</given-names>
        </name>
        <aff><institution>Division of Cancer Pathobiology, Children's Hospital of Philadelphia</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Pathology &amp; Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Barash</surname>
          <given-names>Yoseph</given-names>
        </name>
        <!--yosephb@seas.upenn.edu-->
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Computer and Information Science, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, <addr-line>PA</addr-line>, <country country="US">USA</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 215 746 8683; Email: <email>yosephb@seas.upenn.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>05</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-11-11">
      <day>11</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>11</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <volume>52</volume>
    <issue>D1</issue>
    <fpage>D213</fpage>
    <lpage>D221</lpage>
    <history>
      <date date-type="accepted">
        <day>02</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>11</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkad1043.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Quantification of RNA splicing variations based on RNA-Sequencing can reveal tissue- and disease-specific splicing patterns. To study such splicing variations, we introduce MAJIQlopedia, an encyclopedia of splicing variations that encompasses 86 human tissues and 41 cancer datasets. MAJIQlopedia reports annotated and unannotated splicing events for a total of 486 175 alternative splice junctions in normal tissues and 338 317 alternative splice junctions in cancer. This database, available at <ext-link xlink:href="https://majiq.biociphers.org/majiqlopedia/" ext-link-type="uri">https://majiq.biociphers.org/majiqlopedia/</ext-link>, includes a user-friendly interface that provides graphical representations of junction usage quantification for each junction across all tissue or cancer types. To demonstrate case usage of MAJIQlopedia, we review splicing variations in genes <italic toggle="yes">WT1</italic>, <italic toggle="yes">MAPT</italic> and <italic toggle="yes">BIN1</italic>, which all have known tissue or cancer-specific splicing variations. We also use MAJIQlopedia to highlight novel splicing variations in <italic toggle="yes">FDX1</italic> and <italic toggle="yes">MEGF9</italic> in normal tissues, and we uncover a novel exon inclusion event in <italic toggle="yes">RPS6KA6</italic> that only occurs in two cancer types. Users can download the database, request the addition of data to the webtool, or install a MAJIQlopedia server to integrate proprietary data. MAJIQlopedia can serve as a reference database for researchers seeking to understand what splicing variations exist in genes of interest, and those looking to understand tissue- or cancer-specific splice isoform usage.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <graphic xlink:href="gkad1043figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Cancer Research Society</institution>
            <institution-id institution-id-type="DOI">10.13039/100009326</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>990633</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>CA232563</award-id>
        <award-id>LM013437</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>Introduction</title>
    <p>Alternative pre-mRNA splicing is an important component of post-transcriptional gene regulation as variations in the selection of splice sites can alter coding sequence, transcript stability, transcript localization and protein abundance (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Detecting and quantifying isoforms of a given gene can thus quickly inform on possible function and associated regulatory mechanisms. Indeed, gene annotation efforts (e.g. GENCODE, Ensembl) report different isoforms for the vast majority of human genes, yet novel splicing variations are regularly identified when characterizing genes under certain conditions or systems (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>). This indicates that many transcript isoforms remain to be discovered, with some potentially playing key functional roles.</p>
    <p>In normal tissues, tightly regulated splicing programs contribute to specialized tissue or cell type-specific functions (<xref rid="B5" ref-type="bibr">5</xref>). Such dedicated programs have been described in the brain, muscle, epidermis and blood, among other systems. A major hurdle to the identification of additional tissue-specific splicing events is the limited access to cross-tissue analyses and the need to include unannotated splicing variations.</p>
    <p>In contrast to normal splicing variations, disruption of such tissue specific splicing programs has been associated with numerous diseases, cancer in particular (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>). Specifically, splicing disruption is a feature commonly shared between tumor types (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B8" ref-type="bibr">8</xref>) and mutations in proteins controlling splicing can drive oncogenesis (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). On the upside, the abundance of aberrant splicing variations in cancer offers great potential for the development of new therapeutic avenues (<xref rid="B7" ref-type="bibr">7</xref>). The identification of splicing variations as candidate therapeutic targets for a given type of cancer often raises the question about the presence of the same variation in other cancer types.</p>
    <p>Splicing databases are useful tools to interrogate what splicing events occur in what tissues. Available databases come in different forms and address different problems. For example, the GTEx portal (<xref rid="B11" ref-type="bibr">11</xref>) provides exon expression data that can be used to extrapolate what transcript isoforms are used in each of 54 normal tissues. Other resources such as intropolis/Snaptron (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>), VastDB (<xref rid="B14" ref-type="bibr">14</xref>), TSVdb (<xref rid="B15" ref-type="bibr">15</xref>), RJunBase (<xref rid="B16" ref-type="bibr">16</xref>), OncoSplicing (<xref rid="B17" ref-type="bibr">17</xref>), recount3 (<xref rid="B18" ref-type="bibr">18</xref>), MetazExp (<xref rid="B19" ref-type="bibr">19</xref>) and ASCancer Atlas (<xref rid="B20" ref-type="bibr">20</xref>) use different methods to describe splicing variations, using various datasets that can focus on normal human tissues or cancer, or include several species, and may offer a web interface or not (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>).</p>
    <p>Here we present MAJIQlopedia, a database of splicing variations in normal human tissues and cancer. MAJIQlopedia offers two instances, one listing splicing variations found in normal tissues and the second listing variations found in cancer. The normal tissue dataset comprises samples from large-scale projects such as GTEx and BLUEPRINT, but also includes smaller publicly available datasets to provide a comprehensive reference for a total of 86 solid tissue and hematopoietic cell types. The cancer dataset comprises samples from TCGA and Beat-AML as well as pediatric cancer samples from the TARGET and CBTN projects, for a total of 41 cancer cohorts. Compared to existing databases MAJIQlopedia offers several advantages. First is the breadth of the tissue and cancer types included, as described above. Second, its splicing analysis was performed with the MAJIQ algorithm, which has been shown to compare favourably in detection and quantification of alternative splicing (<xref rid="B21" ref-type="bibr">21–23</xref>). MAJIQ formulates alternative splicing as local splicing variations involving splits in a gene's splice graph coming out of or into a reference exon. This allows the MAJIQlopedia to capture complex splicing variations involving more than two splice junctions, as well as unannotated splice sites, junctions, exons and intron retention events (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B21" ref-type="bibr">21</xref>). Such unannotated events are commonly found in cancer (<xref rid="B8" ref-type="bibr">8</xref>). The website optimizes the interface offered by our VOILA module to run quickly on the two very large datasets of cancer and normal samples. The database is accessible online (<ext-link xlink:href="https://majiq.biociphers.org/majiqlopedia/" ext-link-type="uri">https://majiq.biociphers.org/majiqlopedia/</ext-link>) and offers a straightforward query process that facilitates the interrogation of any gene of interest, with a graphical presentation of the data. Users can also request to add data or install their own MAJIQlopedia instance with their data. We used MAJIQlopedia to review cases of known tissue-specific splicing regulation and uncover novel splicing variations in normal tissues and cancer.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>Materials and methods</title>
    <sec id="SEC2-1">
      <title>Datasets</title>
      <p>Seven publicly available datasets were downloaded and processed to generate the normal tissue instance of MAJIQlopedia: GTEx (<xref rid="B24" ref-type="bibr">24</xref>), BLUEPRINT (<xref rid="B25" ref-type="bibr">25</xref>), Leucegene (<xref rid="B26" ref-type="bibr">26</xref>), a T cell sample dataset (<xref rid="B27" ref-type="bibr">27</xref>), a bone sample dataset (<xref rid="B28" ref-type="bibr">28</xref>), a mesenchymal bone marrow dataset (<xref rid="B29" ref-type="bibr">29</xref>) and an osteoblast dataset (<xref rid="B30" ref-type="bibr">30</xref>). These datasets are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>. Four publicly available datasets were downloaded and processed to generate the cancer instance of MAJIQlopedia: TCGA (<xref rid="B31" ref-type="bibr">31</xref>), TARGET (<xref rid="B32" ref-type="bibr">32</xref>), Beat-AML (<xref rid="B33" ref-type="bibr">33</xref>) and CBTN (<xref rid="B34" ref-type="bibr">34</xref>). These datasets are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Data processing</title>
      <p>We limited technical biases by processing all RNA-Seq samples fastq files when possible or by first shuffling bam files and converting to fastq when raw sequencing files were unavailable. Sequencing adapters were trimmed with TrimGalore (v0.6.6) (<xref rid="B35" ref-type="bibr">35</xref>). Reads were aligned with STAR (v2.5.2a) (<xref rid="B36" ref-type="bibr">36</xref>) against the hg38 human genome assembly (<xref rid="B37" ref-type="bibr">37</xref>). Mapped reads were sorted and indexed using samtools (v1.11) (<xref rid="B38" ref-type="bibr">38</xref>). Gene expression quantification was carried out using Salmon (v0.14.0) (<xref rid="B39" ref-type="bibr">39</xref>) in quasi-mapping mode using an index generated with Ensembl GRCh38 transcriptome release 94. Splice junctions were quantified using MAJIQ (v2.2) (<xref rid="B21" ref-type="bibr">21</xref>). MAJIQ defines alternative splicing in terms of local splicing variations (LSVs). For this reason, the same junction can be quantified twice by MAJIQ, i.e. once from the 5′ splice site and once from the 3′ splice site. Duplicate junctions (those that were counted twice) were identified as junctions sharing the exact same coordinates in the same gene. The number of splice junctions given in the text and in the figures correspond to the number of junctions after removing duplicates.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Generation of the MAJIQlopedia data</title>
      <p>Two MAJIQ builds were used to generate MAJIQlopedia, one for normal tissues and one for cancer. The same parameters were used in both cases. Samples belonging to a given tissue or cancer type were grouped together. The MAJIQ build was run using default parameters except for the minimum number of reads required to quantify a junction, which was set at 10 using the --minreads 10 tag. We then applied the MAJIQ PSI and MAJIQ VOILA modules with default parameters to quantify splicing variations.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Protein structure prediction and alignment</title>
      <p>MT1A structures were predicted using ESMFold (<xref rid="B40" ref-type="bibr">40</xref>), and aligned and visualized using the RCSB Protein Database Bank Pairwise Structure Alignment tool (<xref rid="B41" ref-type="bibr">41</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>Results</title>
    <sec id="SEC3-1">
      <title>Generation of MAJIQlopedia</title>
      <p>We assembled publicly available RNA-Seq data from seven sources of normal tissue samples and four sources of cancer samples. Raw sequencing files were re-processed in the same way for all samples to minimize biases and version incompatibility in read alignment methods and reference genome and transcriptome annotations (Figure <xref rid="F1" ref-type="fig">1A</xref>). The quantifications available in MAJIQlopedia represent data from all samples that belong to a certain tissue or cancer type. All tissue types are composed of a minimum of three samples originating from three donors (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1</xref>).</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>MAJIQlopedia content and web interface. (<bold>A</bold>) Strategy used to generate MAJIQlopedia. (<bold>B</bold>) Three simple steps give access to the MAJIQlopedia data for a gene of interest.</p>
        </caption>
        <graphic xlink:href="gkad1043fig1" position="float"/>
      </fig>
      <p>The MAJIQlopedia website allows users to query individual genes through three simple steps, by (i) first choosing whether splicing variations should be shown for normal tissues or cancer, then (ii) entering the name of the gene of interest and finally (iii) visualizing quantifications available for all of the splicing variations that MAJIQ found in our dataset in the selected gene (Figure <xref rid="F1" ref-type="fig">1B</xref>). Quantifications are shown as violin plots and can be downloaded as images. Raw data underlying the generation of these plots are also available as a bulk download for all splice junctions in all tissues from the main page of the website. These data can be used to customize the graphical representation of the data according to the user's need or to perform large-scale analyses across any number of genes.</p>
    </sec>
    <sec id="SEC3-2">
      <title>Summary of the MAJIQlopedia database content</title>
      <p>From 7654 normal and 11 059 cancer samples (Figure <xref rid="F2" ref-type="fig">2A</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1</xref>), we report 210 394 splicing variations totalling 486 175 alternatively used splice junctions in normal tissues and 155 226 splicing variations totalling 338 317 alternatively used splice junctions in cancer. We define variable junctions as junctions involved in a local splicing variation (LSV) event where the junction is used at a minimum of 5% in any tissue. Cancer samples tend to have more unannotated junctions than normal tissues (Figure <xref rid="F2" ref-type="fig">2B</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2</xref>), with splicing variations composed of 20.81% (normal tissues) and 22.98% (cancer) of splice junctions that are unannotated in the Ensembl GRCh38.94 reference transcriptome. The number of alternative splice junctions detected in each tissue ranges from 184 886 (germinal B cells) to 44 293 (mesenchymal bone marrow cells) in normal tissues and 163 580 (high-grade glioma) to 69 032 (diffuse large B-cell lymphoma) in cancer (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2</xref>). These metrics should not be interpreted as a direct measure of the absolute abundance of alternative splicing occurring in a given tissue and should not be compared between tissues because splicing quantifications depend on the read depth of RNA-Seq samples and the number of samples in each tissue/cancer group, which vary between the datasets that we surveyed. Although the database was built separately for normal tissues and cancer, a vast majority of junctions quantified in normal tissues were also found in cancer (Figure <xref rid="F2" ref-type="fig">2C</xref>), making it possible to assess how a given junction is used in both sets.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Overview of the data available in MAJIQlopedia. (<bold>A</bold>) Density plot of the number of samples in each tissue/cancer type. (<bold>B</bold>) Density plot for the relative frequency of unannotated junctions found in normal (grey) and cancer (red) datasets. (<bold>C</bold>) Overlap between variable junctions found in normal tissues and in cancer. (<bold>D</bold>) Number of genes binned by their total number of variable splice junctions in any tissue in normal tissues (left) and cancer (right).</p>
        </caption>
        <graphic xlink:href="gkad1043fig2" position="float"/>
      </fig>
      <p>We next wondered how many variable splice junctions are found in each gene. About a quarter of genes quantified in MAJIQlopedia display little alternative splicing, with fewer than five variable junctions (Figure <xref rid="F2" ref-type="fig">2D</xref>). At the other end of the spectrum, 1550 genes have over 50 variable splice junctions in the context of normal tissues. Many of the genes with the largest number of variable junctions in normal tissues are large genes with numerous exons (e.g. <italic toggle="yes">TTN</italic>, 109.2 kb transcript, 363 annotated exons in MANE transcript; <italic toggle="yes">SYNE2</italic>, 21.8kb transcript and 116 annotated exons in MANE transcript; <italic toggle="yes">HERC1</italic>, 15.2 kb transcript and 78 annotated exons in MANE transcript). Low but measurable levels of intron retention exist in some tissues for these genes, which contributes to the high number of variable junctions reported (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 3A</xref>). When normalizing the number of variable splice junctions by the number of exons in the canonical transcript annotation of protein-coding genes (MANE or Ensembl Canonical transcripts), we find that genes with high levels of splice junction variation display complex splicing patterns. These variations can involve annotated (e.g. <italic toggle="yes">CMC2</italic>, <italic toggle="yes">ZNF655</italic>) or unannotated (e.g. <italic toggle="yes">UBC</italic>, <italic toggle="yes">MRPL43</italic>) splice junctions (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 3B</xref>).</p>
    </sec>
    <sec id="SEC3-3">
      <title>Tissue-regulated splicing variations in MAJIQlopedia</title>
      <p>We sought to illustrate how the quantifications provided in MAJIQlopedia correspond to the splicing patterns expected from the literature for well-known cases of disease-associated alternative splicing events. In the <italic toggle="yes">WT1</italic> gene, skipping of exon 5 is frequent in Wilms tumor, where a common mutation alters the splice donor downstream of exon 5 (<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>). In line with the literature, MAJIQlopedia shows that Wilms tumor samples have lower exon 5 inclusion levels than other cancer types such as acute myeloid leukemia, mesothelioma or ovarian cancer (Figure <xref rid="F3" ref-type="fig">3A</xref>). In the <italic toggle="yes">MAPT</italic> gene, skipping of exon 10 results in the loss of one of four microtubule-binding sequences and the ratio between exon 10 inclusion and skipping likely impacts neurodegeneration in tauopathies (<xref rid="B44" ref-type="bibr">44–46</xref>). Another alternative splicing event in <italic toggle="yes">MAPT</italic> concerns the inclusion of exon 3, which is associated with Parkinsonian disorders (<xref rid="B47" ref-type="bibr">47</xref>). The inclusion of both of these exons varies by brain region (<xref rid="B48" ref-type="bibr">48</xref>,<xref rid="B49" ref-type="bibr">49</xref>). As expected, MAJIQlopedia shows variable inclusion levels between brain regions for both exon 3 and exon 10 (Figure <xref rid="F3" ref-type="fig">3B</xref>). Intriguingly, <italic toggle="yes">MAPT</italic> exons 3 and 10 are also alternatively used in cancer (Figure <xref rid="F3" ref-type="fig">3B</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Visualization of known tissue-specific alternative splicing variations. (<bold>A</bold>) Inclusion levels of an alternative exon in <italic toggle="yes">WT1</italic> are lower in Wilms tumor samples (TARGET-WT) than in testis or in other cancers (Beat-AML, TCGA-MESO, TCGA-OV). (<bold>B</bold>) Two highly variable alternative exons in <italic toggle="yes">MAPT</italic> have tissue- and cancer-specific usage profiles. (<bold>C</bold>) MAJIQlopedia highlights the neural-specific inclusion of exon 7 (green junction) as well as the muscle-specific inclusion of exon 11 (blue junction) in the <italic toggle="yes">BIN1</italic> gene. Shaded boxes were added to highlight brain tissues (top) and muscle (bottom). Additional splicing variations downstream of exon 12 are detailed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4</xref>. Open boxes between exons represent intron retention events. Quantification panels in (A) and (B) were generated from the data available for download on the home page of MAJIQlopedia, while the quantification panels shown in (C) are screenshots of the MAJIQlopedia website. Boxplots (mostly hidden by violin plots) show 25th and 75th percentiles with whiskers at the 5th and 95th percentiles.</p>
        </caption>
        <graphic xlink:href="gkad1043fig3" position="float"/>
      </fig>
      <p>We also looked into normal tissue-specific splicing patterns. The <italic toggle="yes">BIN1</italic> gene is known for differential inclusion of an exon in neural tissues and a separate exon differentially included in muscle (<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B51" ref-type="bibr">51</xref>). Interrogating MAJIQlopedia for <italic toggle="yes">BIN1</italic> allowed us to quickly appreciate how inclusion of BIN exon 7 is restricted to tissues from the nervous system, whereas inclusion of exon 11 is mostly restricted to muscle (Figure <xref rid="F3" ref-type="fig">3C</xref>). Additional known splicing variations involving exons 14–17 are also represented in the database with complex and highly variable splicing patterns in normal tissues (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4A</xref>). Interestingly, we observed that inclusion of the neural exon 7 and inclusion of the muscle exon 11 also occur in neuroblastoma and head and neck cancer, respectively (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4B</xref>). These results are in line with the fact that, while anatomically distinct from the nervous system, neuroblastoma originates from neural cells (<xref rid="B52" ref-type="bibr">52</xref>). As for the inclusion of exon 11 in head and neck cancer (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4B</xref>), this event could reflect the tissue of origin of the cancer, since exon 11 is also included in the salivary gland (Figure <xref rid="F3" ref-type="fig">3C</xref>), albeit at lower levels than in muscle.</p>
    </sec>
    <sec id="SEC3-4">
      <title>Discovery of novel splicing variations</title>
      <p>In order to demonstrate the value of MAJIQlopedia for the identification of novel alternative splicing events, we asked whether splicing variations exist in genes for which only one transcript has been annotated in Ensembl (<xref rid="B53" ref-type="bibr">53</xref>), GENCODE (<xref rid="B54" ref-type="bibr">54</xref>) and RefSeq (<xref rid="B55" ref-type="bibr">55</xref>), and no splicing variations were previously reported. We found such variations in multiple genes, including in <italic toggle="yes">FDX1</italic> and <italic toggle="yes">MEGF9</italic>. The mitochondrial ferredoxin gene <italic toggle="yes">FDX1</italic> is involved in the synthesis of steroid hormones. The gene has four exons but only one annotated transcript. PubMed searches return no publications mentioning alternative splicing or the existence of transcript isoforms in <italic toggle="yes">FDX1</italic>. However, MAJIQlopedia shows that a novel 159nt exon between exons 3 and 4 has inclusion levels of 13% specifically in hematopoietic stem cells (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 5A</xref>). MEGF9 is a putative transmembrane receptor that is developmentally regulated. <italic toggle="yes">MEGF9</italic> has 6 exons and, just like <italic toggle="yes">FDX1</italic>, only one annotated transcript and no publication mentions alternative splicing or multiple isoforms for <italic toggle="yes">MEGF9</italic>. We discovered that alpha-beta CD4+ T cells, monocytes and neutrophils use a novel 123nt exon between exons 2 and 3 of <italic toggle="yes">MEGF9</italic> with inclusion levels of 15% (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 5B</xref>).</p>
      <p>In both cases, the novel exons preserve the reading frame but introduce stop codons in the coding sequence. The <italic toggle="yes">FDX1</italic> exon encodes two consecutive stop codons in the penultimate exon. The fate of the <italic toggle="yes">FDX1</italic> transcript that includes the novel exon is uncertain because transcripts with premature stop codons close to the end of the coding sequence, including in the penultimate exons, can escape nonsense mediated decay (<xref rid="B56" ref-type="bibr">56</xref>). If escaping nonsense mediated decay, this transcript would encode an FDX1 protein isoform lacking the last 13 residues of the 2Fe-2S ferredoxin-type domain. On the other hand, the <italic toggle="yes">MEGF9</italic> exon introduces three stop codons several exons upstream of the last exon. It can be expected that the inclusion of the novel MEGF9 exon renders the transcripts sensitive to nonsense-mediated decay. In line with this assumption, we find that neutrophil and monocyte samples that have high inclusion of the novel exon also have lower <italic toggle="yes">MEGF9</italic> transcript levels (Supplementary Figure 5C). The use of NMD-inducing exons, often referred to as ‘poison exons’, is a known mechanism for regulating gene expression (<xref rid="B57" ref-type="bibr">57</xref>). Whether the novel exon is involved in the regulation of MEGF9 levels will require further investigation.</p>
      <p>We also found a novel splicing event in the metallothionein <italic toggle="yes">MT1A</italic> gene, which is involved in metal detoxification and oxidative stress prediction. We observed that alternative skipping of <italic toggle="yes">MT1A</italic> exon 2 is an isoform that co-exists with the only known transcript at variable levels ranging from 10% to 20% in all solid tissues where the variation is quantified (Figure <xref rid="F4" ref-type="fig">4A</xref>). Skipping of exon 2 preserves the reading frame of the coding sequence, but removes 22aa in the beta domain of the protein (Figure <xref rid="F4" ref-type="fig">4B</xref>). The predicted structure for the skipped isoform aligns well with the canonical isoform and shows that the alpha domain is mostly preserved (Figure <xref rid="F4" ref-type="fig">4B</xref>). The loss of the beta domain would reduce the binding capacity of the protein from seven metal atoms to four and prevent the formation of the supermetalated intermediate MT1A species (<xref rid="B58" ref-type="bibr">58</xref>).</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>Novel alternative splicing events highlighted by MAJIQlopedia. (<bold>A</bold>) A novel cassette exon skipping event (blue junctions) in <italic toggle="yes">MT1A</italic> is used in a large array of tissues. (<bold>B</bold>) The <italic toggle="yes">MT1A</italic> skipping event results in the truncation of the beta domain, but preserves the alpha domain. (<bold>C</bold>) A novel exon inclusion event in the <italic toggle="yes">RPS6KA6</italic> is only found in a pediatric high-grade glioma cohort and a pediatric clear cell sarcoma of the kidney cohort. The splicegraphs at the top show that MAJIQlopedia contains no evidence of alternative splicing in normal tissues, but some variations in cancer, most notably the inclusion of a novel exon between exons 2 and 3. (<bold>D</bold>) Raw reads compiled from 13 samples of clear cell sarcoma of the kidney confirming novel exon inclusion. (<bold>E</bold>) Exon 2a inclusion levels compared to total gene expression of RPS6KA6 in high-grade glioma and clear cell sarcoma of the kidney samples.</p>
        </caption>
        <graphic xlink:href="gkad1043fig4" position="float"/>
      </fig>
      <p>Finally, we wondered if MAJIQlopedia contained information about splicing variations that occur in cancer, but not in normal tissues. There are 822 genes that have at least two alternative splice junctions in at least one cancer type, but no alternative junction used over 5% in any normal tissue. One of those genes is the ribosomal kinase <italic toggle="yes">RPS6KA6</italic> gene, which only has one annotated transcript. In agreement with the literature, no splicing variations are observed in normal tissues. However, MAJIQlopedia shows that there is inclusion of a novel exon between exons 2 and 3 of <italic toggle="yes">RPS6KA6</italic> in pediatric cohorts of high-grade glioma and clear cell sarcoma of the kidney at level of 15% and 25%, respectively (Figure <xref rid="F4" ref-type="fig">4C</xref>). Inspection of raw read alignments confirms the inclusion of the novel exon, labeled as ‘exon 2a’ (Figure <xref rid="F4" ref-type="fig">4D</xref>). While exon 2a shifts the reading frame of the coding sequence and introduces several stop codons, there is no clear relationship between the level of exon 2a inclusion and lower transcript levels in the two cancer cohorts that we looked at (Figure <xref rid="F4" ref-type="fig">4E</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="discussion" id="SEC4">
    <title>Discussion</title>
    <p>In this work, we introduce MAJIQlopedia, a new database with a matching webtool, for exploring splicing variations across normal and cancer samples. Using several examples, we illustrate how MAJIQlopedia can be used to analyze known splicing variations as well as a hypothesis generator, identifying novel splicing variations that are tissue or cancer specific. In addition, users can submit requests to add data or install their own private instance with specific data of interest.</p>
    <p>One caveat of MAJIQlopedia is that it does not include developmental tissues. We hope to address this in future updates as new datasets become available. Another limitation is that we are unable to include sample level information. This limitation is due to data access restrictions and not inherent to the tool as both MAJIQ and the visualization package VOILA can display such information. Another future direction to enhance MAJIQlopedia is to incorporate long-reads and full isoform information. It is also important to note that the information provided in MAJIQlopedia, as for all other splicing databases, is not well suited to perform differential splicing analyses between conditions. For such tests users should instead run MAJIQ directly for conditions of interest and consider running MOCCASIN to correct for unknown or known confounders such as batch effects (<xref rid="B59" ref-type="bibr">59</xref>).</p>
    <p>Overall, we believe that MAJIQlopedia, with its unique set of features, supported datasets, and ease of use, will be of great value to the large community of researchers seeking to understand how the expression of their favorite genes might be regulated and those looking to understand tissue- or cancer-specific splice isoform usage.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkad1043_Supplemental_Files</label>
      <media xlink:href="gkad1043_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>Acknowledgements</title>
    <p>We thank early users of MAJIQlopedia from the Thomas-Tikhonenko, Barash and Lynch labs for the feedback they have provided on the webtool.</p>
  </ack>
  <sec sec-type="data-availability" id="SEC5">
    <title>Data availability</title>
    <p>The data underlying MAJIQlopedia is publicly available, with restricted access in some cases, from the sources listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S2 and S3</xref>.</p>
  </sec>
  <sec id="SEC6">
    <title>Supplementary data</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad1043#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>Funding</title>
    <p>Next Generation of Scientists Award from the Cancer Research Society [990633 to M.Q.V.]; U01 and R01 grants from National Institutes of Health [CA232563 to A.T.T., K.W.L. and Y.B.; LM013437 to Y.B.]. Funding for open access charge: NIH [U01 CA232563].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <notes id="NT1">
    <title>Notes</title>
    <p>Present address: Mathieu Quesnel-Vallières, Department of Immunology and Cell Biology, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.</p>
  </notes>
  <ref-list id="REF1">
    <title>References</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Rio</surname><given-names>D.C.</given-names></string-name></person-group><article-title>Mechanisms and regulation of alternative pre-mRNA splicing</article-title>. <source>Annu. Rev. Biochem.</source><year>2015</year>; <volume>84</volume>:<fpage>291</fpage>–<lpage>323</lpage>.<pub-id pub-id-type="pmid">25784052</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gallego-Paez</surname><given-names>L.M.</given-names></string-name>, <string-name><surname>Bordone</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Leote</surname><given-names>A.C.</given-names></string-name>, <string-name><surname>Saraiva-Agostinho</surname><given-names>N.</given-names></string-name>, <string-name><surname>Ascensão-Ferreira</surname><given-names>M.</given-names></string-name>, <string-name><surname>Barbosa-Morais</surname><given-names>N.L.</given-names></string-name></person-group><article-title>Alternative splicing: the pledge, the turn, and the prestige</article-title>. <source>Hum. Genet.</source><year>2017</year>; <volume>136</volume>:<fpage>1015</fpage>–<lpage>1042</lpage>.<pub-id pub-id-type="pmid">28374191</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Barrera</surname><given-names>A.</given-names></string-name>, <string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>González-Vallinas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Hogenesch</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title>. <source>eLife</source>. <year>2016</year>; <volume>5</volume>:<fpage>e11752</fpage>.<pub-id pub-id-type="pmid">26829591</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aguet</surname><given-names>F.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Castel</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>He</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jo</surname><given-names>B.</given-names></string-name>, <string-name><surname>Mohammadi</surname><given-names>P.</given-names></string-name>, <string-name><surname>Park</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Parsana</surname><given-names>P.</given-names></string-name>, <string-name><surname>Segrè</surname><given-names>A.V.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Genetic effects on gene expression across human tissues</article-title>. <source>Nature</source>. <year>2017</year>; <volume>550</volume>:<fpage>204</fpage>–<lpage>213</lpage>.<pub-id pub-id-type="pmid">29022597</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ule</surname><given-names>J.</given-names></string-name>, <string-name><surname>Blencowe</surname><given-names>B.J.</given-names></string-name></person-group><article-title>Alternative splicing regulatory networks: functions, mechanisms, and evolution</article-title>. <source>Mol. Cell</source>. <year>2019</year>; <volume>76</volume>:<fpage>329</fpage>–<lpage>345</lpage>.<pub-id pub-id-type="pmid">31626751</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>G.-S.</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>T.A.</given-names></string-name></person-group><article-title>Splicing in disease: disruption of the splicing code and the decoding machinery</article-title>. <source>Nat. Rev. Genet.</source><year>2007</year>; <volume>8</volume>:<fpage>749</fpage>–<lpage>761</lpage>.<pub-id pub-id-type="pmid">17726481</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stanley</surname><given-names>R.F.</given-names></string-name>, <string-name><surname>Abdel-Wahab</surname><given-names>O</given-names></string-name></person-group><article-title>Dysregulation and therapeutic targeting of RNA splicing in cancer</article-title>. <source>Nat Cancer</source>. <year>2022</year>; <volume>3</volume>:<fpage>536</fpage>–<lpage>546</lpage>.<pub-id pub-id-type="pmid">35624337</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quesnel-Vallières</surname><given-names>M.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Thomas-Tikhonenko</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>Identifying common transcriptome signatures of cancer by interpreting deep learning models</article-title>. <source>Genome Biol.</source><year>2022</year>; <volume>23</volume>:<fpage>117</fpage>.<pub-id pub-id-type="pmid">35581644</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anczuków</surname><given-names>O.</given-names></string-name>, <string-name><surname>Krainer</surname><given-names>A.R.</given-names></string-name></person-group><article-title>Splicing-factor alterations in cancers</article-title>. <source>RNA</source>. <year>2016</year>; <volume>22</volume>:<fpage>1285</fpage>–<lpage>1301</lpage>.<pub-id pub-id-type="pmid">27530828</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Escobar-Hoyos</surname><given-names>L.</given-names></string-name>, <string-name><surname>Knorr</surname><given-names>K.</given-names></string-name>, <string-name><surname>Abdel-Wahab</surname><given-names>O.</given-names></string-name></person-group><article-title>Aberrant RNA splicing in cancer</article-title>. <source>Annual Review of Cancer Biology</source>. <year>2019</year>; <volume>3</volume>:<fpage>167</fpage>–<lpage>185</lpage>.</mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Consortium</surname><given-names>T.G.T.E.</given-names></string-name>, <string-name><surname>Ardlie</surname><given-names>K.G.</given-names></string-name>, <string-name><surname>Deluca</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Segrè</surname><given-names>A.V.</given-names></string-name>, <string-name><surname>Sullivan</surname><given-names>T.J.</given-names></string-name>, <string-name><surname>Young</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Gelfand</surname><given-names>E.T.</given-names></string-name>, <string-name><surname>Trowbridge</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Maller</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Tukiainen</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title>. <source>Science</source>. <year>2015</year>; <volume>348</volume>:<fpage>648</fpage>–<lpage>660</lpage>.<pub-id pub-id-type="pmid">25954001</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nellore</surname><given-names>A.</given-names></string-name>, <string-name><surname>Jaffe</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Fortin</surname><given-names>J.-P.</given-names></string-name>, <string-name><surname>Alquicira-Hernández</surname><given-names>J.</given-names></string-name>, <string-name><surname>Collado-Torres</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Phillips III</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Karbhari</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hansen</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Langmead</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Human splicing diversity and the extent of unannotated splice junctions across human RNA-seq samples on the Sequence Read Archive</article-title>. <source>Genome Biol.</source><year>2016</year>; <volume>17</volume>:<fpage>266</fpage>.<pub-id pub-id-type="pmid">28038678</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Gaddipati</surname><given-names>P.</given-names></string-name>, <string-name><surname>Nellore</surname><given-names>A.</given-names></string-name>, <string-name><surname>Langmead</surname><given-names>B.</given-names></string-name></person-group><article-title>Snaptron: querying splicing patterns across tens of thousands of RNA-seq samples</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>114</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">28968689</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tapial</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ha</surname><given-names>K.C.H.</given-names></string-name>, <string-name><surname>Sterne-Weiler</surname><given-names>T.</given-names></string-name>, <string-name><surname>Gohr</surname><given-names>A.</given-names></string-name>, <string-name><surname>Braunschweig</surname><given-names>U.</given-names></string-name>, <string-name><surname>Hermoso-Pulido</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quesnel-Vallières</surname><given-names>M.</given-names></string-name>, <string-name><surname>Permanyer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sodaei</surname><given-names>R.</given-names></string-name>, <string-name><surname>Marquez</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms</article-title>. <source>Genome Res.</source><year>2017</year>; <volume>27</volume>:<fpage>1759</fpage>–<lpage>1768</lpage>.<pub-id pub-id-type="pmid">28855263</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>W.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name></person-group><article-title>TSVdb: a web-tool for TCGA splicing variants analysis</article-title>. <source>BMC Genomics</source>. <year>2018</year>; <volume>19</volume>:<fpage>405</fpage>.<pub-id pub-id-type="pmid">29843604</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Meng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Z.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RJunBase: a database of RNA splice junctions in human normal and cancerous tissues</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D201</fpage>–<lpage>D211</lpage>.<pub-id pub-id-type="pmid">33179749</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Tian</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>C.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>50</volume>:<fpage>D1340</fpage>–<lpage>D1347</lpage>.</mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F.Y.</given-names></string-name>, <string-name><surname>Charles</surname><given-names>R.</given-names></string-name>, <string-name><surname>Solomon</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ling</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Imada</surname><given-names>E.L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Joseph</surname><given-names>L.</given-names></string-name>, <string-name><surname>Leek</surname><given-names>J.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>recount3: summaries and queries for large-scale RNA-seq expression and splicing</article-title>. <source>Genome Biol.</source><year>2021</year>; <volume>22</volume>:<fpage>323</fpage>.<pub-id pub-id-type="pmid">34844637</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lang</surname><given-names>K.</given-names></string-name>, <string-name><surname>Jie</surname><given-names>W.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>W.</given-names></string-name></person-group><article-title>MetazExp: a database for gene expression and alternative splicing profiles and their analyses based on 53 615 public RNA-seq samples in 72 metazoan species</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>50</volume>:<fpage>D1046</fpage>–<lpage>D1054</lpage>.</mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zong</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>W.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>P.</given-names></string-name>, <string-name><surname>Li</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>51</volume>:<fpage>D1196</fpage>–<lpage>D1204</lpage>.</mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Aicher</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Jewell</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Radens</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Norton</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>RNA splicing analysis using heterogeneous and large RNA-seq datasets</article-title>. <source>Nat. Commun.</source><year>2023</year>; <volume>14</volume>:<fpage>1230</fpage>.<pub-id pub-id-type="pmid">36869033</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Norton</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>Outlier detection for improved differential splicing quantification from RNA-Seq experiments with replicates</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>1488</fpage>–<lpage>1497</lpage>.<pub-id pub-id-type="pmid">29236961</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mehmood</surname><given-names>A.</given-names></string-name>, <string-name><surname>Laiho</surname><given-names>A.</given-names></string-name>, <string-name><surname>Venäläinen</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>McGlinchey</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>N.</given-names></string-name>, <string-name><surname>Elo</surname><given-names>L.L.</given-names></string-name></person-group><article-title>Systematic evaluation of differential splicing tools for RNA-seq studies</article-title>. <source>Briefings Bioinf.</source><year>2020</year>; <volume>21</volume>:<fpage>2052</fpage>–<lpage>2065</lpage>.</mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lonsdale</surname><given-names>J.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Salvatore</surname><given-names>M.</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lo</surname><given-names>E.</given-names></string-name>, <string-name><surname>Shad</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hasz</surname><given-names>R.</given-names></string-name>, <string-name><surname>Walters</surname><given-names>G.</given-names></string-name>, <string-name><surname>Garcia</surname><given-names>F.</given-names></string-name>, <string-name><surname>Young</surname><given-names>N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Genotype-Tissue Expression (GTEx) project</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>580</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">23715323</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adams</surname><given-names>D.</given-names></string-name>, <string-name><surname>Altucci</surname><given-names>L.</given-names></string-name>, <string-name><surname>Antonarakis</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Ballesteros</surname><given-names>J.</given-names></string-name>, <string-name><surname>Beck</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bird</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bock</surname><given-names>C.</given-names></string-name>, <string-name><surname>Boehm</surname><given-names>B.</given-names></string-name>, <string-name><surname>Campo</surname><given-names>E.</given-names></string-name>, <string-name><surname>Caricasole</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>BLUEPRINT to decode the epigenetic signature written in blood</article-title>. <source>Nat. Biotechnol.</source><year>2012</year>; <volume>30</volume>:<fpage>224</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">22398613</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacRae</surname><given-names>T.</given-names></string-name>, <string-name><surname>Sargeant</surname><given-names>T.</given-names></string-name>, <string-name><surname>Lemieux</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hébert</surname><given-names>J.</given-names></string-name>, <string-name><surname>Deneault</surname><given-names>É.</given-names></string-name>, <string-name><surname>Sauvageau</surname><given-names>G.</given-names></string-name></person-group><article-title>RNA-Seq reveals spliceosome and proteasome genes as most consistent transcripts in human cancer cells</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e72884</fpage>.<pub-id pub-id-type="pmid">24069164</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ranzani</surname><given-names>V.</given-names></string-name>, <string-name><surname>Rossetti</surname><given-names>G.</given-names></string-name>, <string-name><surname>Panzeri</surname><given-names>I.</given-names></string-name>, <string-name><surname>Arrigoni</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bonnal</surname><given-names>R.J.P.</given-names></string-name>, <string-name><surname>Curti</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gruarin</surname><given-names>P.</given-names></string-name>, <string-name><surname>Provasi</surname><given-names>E.</given-names></string-name>, <string-name><surname>Sugliano</surname><given-names>E.</given-names></string-name>, <string-name><surname>Marconi</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4</article-title>. <source>Nat. Immunol.</source><year>2015</year>; <volume>16</volume>:<fpage>318</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">25621826</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scott</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Temiz</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Sarver</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>LaRue</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Rathe</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Varshney</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Moriarity</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>O’Brien</surname><given-names>T.D.</given-names></string-name>, <string-name><surname>Spector</surname><given-names>L.G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Comparative transcriptome analysis quantifies immune cell transcript levels, metastatic progression, and survival in osteosarcoma</article-title>. <source>Cancer Res.</source><year>2018</year>; <volume>78</volume>:<fpage>326</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">29066513</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.-W.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>W.-Y.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>F.-J.</given-names></string-name>, <string-name><surname>Luo</surname><given-names>C.-W.</given-names></string-name></person-group><article-title>Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis</article-title>. <source>Cell Commun. Signal.</source><year>2022</year>; <volume>20</volume>:<fpage>190</fpage>.<pub-id pub-id-type="pmid">36443839</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moriarity</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>Otto</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Rahrmann</surname><given-names>E.P.</given-names></string-name>, <string-name><surname>Rathe</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Weg</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Manlove</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>LaRue</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Temiz</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Molyneux</surname><given-names>S.D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis</article-title>. <source>Nat. Genet.</source><year>2015</year>; <volume>47</volume>:<fpage>615</fpage>–<lpage>624</lpage>.<pub-id pub-id-type="pmid">25961939</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weinstein</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Collisson</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Mills</surname><given-names>G.B.</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>K.R.M.</given-names></string-name>, <string-name><surname>Ozenberger</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Ellrott</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shmulevich</surname><given-names>I.</given-names></string-name>, <string-name><surname>Sander</surname><given-names>C.</given-names></string-name>, <string-name><surname>Stuart</surname><given-names>J.M.</given-names></string-name></person-group><article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>1113</fpage>–<lpage>1120</lpage>.<pub-id pub-id-type="pmid">24071849</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname><given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Alexandrov</surname><given-names>L.B.</given-names></string-name>, <string-name><surname>Edmonson</surname><given-names>M.N.</given-names></string-name>, <string-name><surname>Gawad</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Rusch</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Easton</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours</article-title>. <source>Nature</source>. <year>2018</year>; <volume>555</volume>:<fpage>371</fpage>–<lpage>376</lpage>.<pub-id pub-id-type="pmid">29489755</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tyner</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Tognon</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Bottomly</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wilmot</surname><given-names>B.</given-names></string-name>, <string-name><surname>Kurtz</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Savage</surname><given-names>S.L.</given-names></string-name>, <string-name><surname>Long</surname><given-names>N.</given-names></string-name>, <string-name><surname>Schultz</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Traer</surname><given-names>E.</given-names></string-name>, <string-name><surname>Abel</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Functional genomic landscape of acute myeloid leukaemia</article-title>. <source>Nature</source>. <year>2018</year>; <volume>562</volume>:<fpage>526</fpage>–<lpage>531</lpage>.<pub-id pub-id-type="pmid">30333627</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lilly</surname><given-names>J.V.</given-names></string-name>, <string-name><surname>Rokita</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Mason</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Patton</surname><given-names>T.</given-names></string-name>, <string-name><surname>Stefankiewiz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Higgins</surname><given-names>D.</given-names></string-name>, <string-name><surname>Trooskin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Larouci</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Arya</surname><given-names>K.</given-names></string-name>, <string-name><surname>Appert</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science</article-title>. <source>Neoplasia</source>. <year>2022</year>; <volume>35</volume>:<fpage>100846</fpage>.<pub-id pub-id-type="pmid">36335802</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krueger</surname><given-names>F.</given-names></string-name>, <string-name><surname>James</surname><given-names>F.</given-names></string-name>, <string-name><surname>Ewels</surname><given-names>P.</given-names></string-name>, <string-name><surname>Afyounian</surname><given-names>E.</given-names></string-name>, <string-name><surname>Weinstein</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schuster-Boeckler</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hulselmans</surname><given-names>G.</given-names></string-name><collab>sclamons</collab></person-group><article-title>FelixKrueger/TrimGalore: v0.6.10 - add default decompression path</article-title>. <source>Zenodo</source>. <year>2023</year>; <pub-id pub-id-type="doi">10.5281/zenodo.7598955</pub-id>.</mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Schlesinger</surname><given-names>F.</given-names></string-name>, <string-name><surname>Drenkow</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zaleski</surname><given-names>C.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>S.</given-names></string-name>, <string-name><surname>Batut</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chaisson</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gingeras</surname><given-names>T.R.</given-names></string-name></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>15</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hubbard</surname><given-names>T.</given-names></string-name>, <string-name><surname>Barker</surname><given-names>D.</given-names></string-name>, <string-name><surname>Birney</surname><given-names>E.</given-names></string-name>, <string-name><surname>Cameron</surname><given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cox</surname><given-names>T.</given-names></string-name>, <string-name><surname>Cuff</surname><given-names>J.</given-names></string-name>, <string-name><surname>Curwen</surname><given-names>V.</given-names></string-name>, <string-name><surname>Down</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Ensembl genome database project</article-title>. <source>Nucleic Acids Res.</source><year>2002</year>; <volume>30</volume>:<fpage>38</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">11752248</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>1000 Genome Project Data Processing Subgroup</collab><string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Handsaker</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wysoker</surname><given-names>A.</given-names></string-name>, <string-name><surname>Fennell</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Homer</surname><given-names>N.</given-names></string-name>, <string-name><surname>Marth</surname><given-names>G.</given-names></string-name>, <string-name><surname>Abecasis</surname><given-names>G.</given-names></string-name>, <string-name><surname>Durbin</surname><given-names>R.</given-names></string-name></person-group><article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>2078</fpage>–<lpage>2079</lpage>.<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Patro</surname><given-names>R.</given-names></string-name>, <string-name><surname>Duggal</surname><given-names>G.</given-names></string-name>, <string-name><surname>Love</surname><given-names>M.I.</given-names></string-name>, <string-name><surname>Irizarry</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Kingsford</surname><given-names>C.</given-names></string-name></person-group><article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title>. <source>Nat. Methods</source>. <year>2017</year>; <volume>14</volume>:<fpage>417</fpage>–<lpage>419</lpage>.<pub-id pub-id-type="pmid">28263959</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Akin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Rao</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hie</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>W.</given-names></string-name>, <string-name><surname>Smetanin</surname><given-names>N.</given-names></string-name>, <string-name><surname>Verkuil</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kabeli</surname><given-names>O.</given-names></string-name>, <string-name><surname>Shmueli</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Evolutionary-scale prediction of atomic-level protein structure with a language model</article-title>. <source>Science</source>. <year>2023</year>; <volume>379</volume>:<fpage>1123</fpage>–<lpage>1130</lpage>.<pub-id pub-id-type="pmid">36927031</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berman</surname><given-names>H.M.</given-names></string-name>, <string-name><surname>Westbrook</surname><given-names>J.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Gilliland</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bhat</surname><given-names>T.N.</given-names></string-name>, <string-name><surname>Weissig</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shindyalov</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Bourne</surname><given-names>P.E.</given-names></string-name></person-group><article-title>The Protein Data Bank</article-title>. <source>Nucleic Acids Res.</source><year>2000</year>; <volume>28</volume>:<fpage>235</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Simms</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>Algar</surname><given-names>E.M.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>P.J.</given-names></string-name></person-group><article-title>Splicing of exon 5 in the WT1 gene is disrupted in Wilms’ tumour</article-title>. <source>Eur. J. Cancer</source>. <year>1995</year>; <volume>31</volume>:<fpage>2270</fpage>–<lpage>2276</lpage>.</mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schneider</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wildhardt</surname><given-names>G.</given-names></string-name>, <string-name><surname>Ludwig</surname><given-names>R.</given-names></string-name>, <string-name><surname>Royer-Pokora</surname><given-names>B.</given-names></string-name></person-group><article-title>Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms’ tumor and severe genital malformations</article-title>. <source>Hum. Genet.</source><year>1993</year>; <volume>91</volume>:<fpage>599</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="pmid">8393425</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hernández</surname><given-names>F.</given-names></string-name>, <string-name><surname>Pérez</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lucas</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Mata</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Bhat</surname><given-names>R.</given-names></string-name>, <string-name><surname>Avila</surname><given-names>J.</given-names></string-name></person-group><article-title>Glycogen synthase kinase-3 plays a crucial role in Tau exon 10 splicing and intranuclear distribution of SC35: implications for Alzheimer's disease</article-title>. <source>J. Biol. Chem.</source><year>2004</year>; <volume>279</volume>:<fpage>3801</fpage>–<lpage>3806</lpage>.<pub-id pub-id-type="pmid">14602710</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name></person-group><article-title>Alternative splicing: human disease and quantitative analysis from high-throughput sequencing</article-title>. <source>Comput. Struct. Biotechnol. J.</source><year>2020</year>; <volume>19</volume>:<fpage>183</fpage>–<lpage>195</lpage>.<pub-id pub-id-type="pmid">33425250</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>F.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>C.-X.</given-names></string-name></person-group><article-title>Tau exon 10 alternative splicing and tauopathies</article-title>. <source>Mol. Neurodegener.</source><year>2008</year>; <volume>3</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">18616804</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lai</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Bechy</surname><given-names>A.-L.</given-names></string-name>, <string-name><surname>Denk</surname><given-names>F.</given-names></string-name>, <string-name><surname>Collins</surname><given-names>E.</given-names></string-name>, <string-name><surname>Gavriliouk</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zaugg</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Ryan</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Wade-Martins</surname><given-names>R.</given-names></string-name>, <string-name><surname>Caffrey</surname><given-names>T.M.</given-names></string-name></person-group><article-title>Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders</article-title>. <source>Mol.r Neurodegener.</source><year>2017</year>; <volume>12</volume>:<fpage>79</fpage>.</mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trabzuni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wray</surname><given-names>S.</given-names></string-name>, <string-name><surname>Vandrovcova</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ramasamy</surname><given-names>A.</given-names></string-name>, <string-name><surname>Walker</surname><given-names>R.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>C.</given-names></string-name>, <string-name><surname>Luk</surname><given-names>C.</given-names></string-name>, <string-name><surname>Gibbs</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Dillman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hernandez</surname><given-names>D.G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies</article-title>. <source>Hum. Mol. Genet.</source><year>2012</year>; <volume>21</volume>:<fpage>4094</fpage>–<lpage>4103</lpage>.<pub-id pub-id-type="pmid">22723018</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corsi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bombieri</surname><given-names>C.</given-names></string-name>, <string-name><surname>Valenti</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Romanelli</surname><given-names>M.G.</given-names></string-name></person-group><article-title>Tau Isoforms: gaining Insight into MAPT Alternative Splicing</article-title>. <source>Int. J. Mol. Sci.</source><year>2022</year>; <volume>23</volume>:<fpage>15383</fpage>.<pub-id pub-id-type="pmid">36499709</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>In silico to in vivo splicing analysis using splicing code models</article-title>. <source>Methods</source>. <year>2014</year>; <volume>67</volume>:<fpage>3</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">24321485</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Nagel</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Fagg</surname><given-names>W.S.</given-names></string-name>, <string-name><surname>Shiue</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cline</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Perriman</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Donohue</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Ares</surname><given-names>M.</given-names></string-name></person-group><article-title>Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation</article-title>. <source>RNA</source>. <year>2013</year>; <volume>19</volume>:<fpage>627</fpage>–<lpage>638</lpage>.<pub-id pub-id-type="pmid">23525800</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnsen</surname><given-names>J.I.</given-names></string-name>, <string-name><surname>Dyberg</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wickström</surname><given-names>M.</given-names></string-name></person-group><article-title>Neuroblastoma—a neural crest derived embryonal malignancy</article-title>. <source>Front. Mol. Neurosci.</source><year>2019</year>; <volume>12</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">30760980</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cunningham</surname><given-names>F.</given-names></string-name>, <string-name><surname>Allen</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Allen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Alvarez-Jarreta</surname><given-names>J.</given-names></string-name>, <string-name><surname>Amode</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Armean</surname><given-names>I.M.</given-names></string-name>, <string-name><surname>Austine-Orimoloye</surname><given-names>O.</given-names></string-name>, <string-name><surname>Azov</surname><given-names>A.G.</given-names></string-name>, <string-name><surname>Barnes</surname><given-names>I.</given-names></string-name>, <string-name><surname>Bennett</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Ensembl 2022</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D988</fpage>–<lpage>D995</lpage>.<pub-id pub-id-type="pmid">34791404</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frankish</surname><given-names>A.</given-names></string-name>, <string-name><surname>Diekhans</surname><given-names>M.</given-names></string-name>, <string-name><surname>Jungreis</surname><given-names>I.</given-names></string-name>, <string-name><surname>Lagarde</surname><given-names>J.</given-names></string-name>, <string-name><surname>Loveland</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Mudge</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Sisu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Armstrong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Barnes</surname><given-names>I.</given-names></string-name><etal>et al</etal>.</person-group><article-title>GENCODE 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D916</fpage>–<lpage>D923</lpage>.<pub-id pub-id-type="pmid">33270111</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Leary</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>M.W.</given-names></string-name>, <string-name><surname>Brister</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Ciufo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Haddad</surname><given-names>D.</given-names></string-name>, <string-name><surname>McVeigh</surname><given-names>R.</given-names></string-name>, <string-name><surname>Rajput</surname><given-names>B.</given-names></string-name>, <string-name><surname>Robbertse</surname><given-names>B.</given-names></string-name>, <string-name><surname>Smith-White</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ako-Adjei</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D733</fpage>–<lpage>D745</lpage>.<pub-id pub-id-type="pmid">26553804</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Supek</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lehner</surname><given-names>B.</given-names></string-name>, <string-name><surname>Lindeboom</surname><given-names>R.G.H.</given-names></string-name></person-group><article-title>To NMD or not to NMD: nonsense-mediated mRNA decay in cancer and other genetic diseases</article-title>. <source>Trends Genet.</source><year>2021</year>; <volume>37</volume>:<fpage>657</fpage>–<lpage>668</lpage>.<pub-id pub-id-type="pmid">33277042</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leclair</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Brugiolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Urbanski</surname><given-names>L.</given-names></string-name>, <string-name><surname>Lawson</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Thakar</surname><given-names>K.</given-names></string-name>, <string-name><surname>Yurieva</surname><given-names>M.</given-names></string-name>, <string-name><surname>George</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hinson</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>A.</given-names></string-name>, <string-name><surname>Graveley</surname><given-names>B.R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Poison exon splicing regulates a coordinated network of SR protein expression during differentiation and tumorigenesis</article-title>. <source>Mol. Cell</source>. <year>2020</year>; <volume>80</volume>:<fpage>648</fpage>–<lpage>665</lpage>.<pub-id pub-id-type="pmid">33176162</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sutherland</surname><given-names>D.E.K.</given-names></string-name>, <string-name><surname>Willans</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Stillman</surname><given-names>M.J.</given-names></string-name></person-group><article-title>Single domain metallothioneins: supermetalation of human MT 1a</article-title>. <source>J. Am. Chem. Soc.</source><year>2012</year>; <volume>134</volume>:<fpage>3290</fpage>–<lpage>3299</lpage>.<pub-id pub-id-type="pmid">22242602</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Slaff</surname><given-names>B.</given-names></string-name>, <string-name><surname>Radens</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Jewell</surname><given-names>P.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Thomas-Tikhonenko</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>MOCCASIN: a method for correcting for known and unknown confounders in RNA splicing analysis</article-title>. <source>Nat. Commun.</source><year>2021</year>; <volume>12</volume>:<fpage>3353</fpage>.<pub-id pub-id-type="pmid">34099673</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10767883</article-id>
    <article-id pub-id-type="pmid">37953365</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkad1043</article-id>
    <article-id pub-id-type="publisher-id">gkad1043</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MAJIQlopedia: an encyclopedia of RNA splicing variations in human tissues and cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9945-8123</contrib-id>
        <name>
          <surname>Quesnel-Vallières</surname>
          <given-names>Mathieu</given-names>
        </name>
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Biochemistry and Biophysics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jewell</surname>
          <given-names>San</given-names>
        </name>
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0120-8079</contrib-id>
        <name>
          <surname>Lynch</surname>
          <given-names>Kristen W</given-names>
        </name>
        <aff><institution>Department of Biochemistry and Biophysics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2739-2206</contrib-id>
        <name>
          <surname>Thomas-Tikhonenko</surname>
          <given-names>Andrei</given-names>
        </name>
        <aff><institution>Division of Cancer Pathobiology, Children's Hospital of Philadelphia</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Pathology &amp; Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Barash</surname>
          <given-names>Yoseph</given-names>
        </name>
        <!--yosephb@seas.upenn.edu-->
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Computer and Information Science, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, <addr-line>PA</addr-line>, <country country="US">USA</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 215 746 8683; Email: <email>yosephb@seas.upenn.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>05</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-11-11">
      <day>11</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>11</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <volume>52</volume>
    <issue>D1</issue>
    <fpage>D213</fpage>
    <lpage>D221</lpage>
    <history>
      <date date-type="accepted">
        <day>02</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>11</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkad1043.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Quantification of RNA splicing variations based on RNA-Sequencing can reveal tissue- and disease-specific splicing patterns. To study such splicing variations, we introduce MAJIQlopedia, an encyclopedia of splicing variations that encompasses 86 human tissues and 41 cancer datasets. MAJIQlopedia reports annotated and unannotated splicing events for a total of 486 175 alternative splice junctions in normal tissues and 338 317 alternative splice junctions in cancer. This database, available at <ext-link xlink:href="https://majiq.biociphers.org/majiqlopedia/" ext-link-type="uri">https://majiq.biociphers.org/majiqlopedia/</ext-link>, includes a user-friendly interface that provides graphical representations of junction usage quantification for each junction across all tissue or cancer types. To demonstrate case usage of MAJIQlopedia, we review splicing variations in genes <italic toggle="yes">WT1</italic>, <italic toggle="yes">MAPT</italic> and <italic toggle="yes">BIN1</italic>, which all have known tissue or cancer-specific splicing variations. We also use MAJIQlopedia to highlight novel splicing variations in <italic toggle="yes">FDX1</italic> and <italic toggle="yes">MEGF9</italic> in normal tissues, and we uncover a novel exon inclusion event in <italic toggle="yes">RPS6KA6</italic> that only occurs in two cancer types. Users can download the database, request the addition of data to the webtool, or install a MAJIQlopedia server to integrate proprietary data. MAJIQlopedia can serve as a reference database for researchers seeking to understand what splicing variations exist in genes of interest, and those looking to understand tissue- or cancer-specific splice isoform usage.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <graphic xlink:href="gkad1043figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Cancer Research Society</institution>
            <institution-id institution-id-type="DOI">10.13039/100009326</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>990633</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>CA232563</award-id>
        <award-id>LM013437</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>Introduction</title>
    <p>Alternative pre-mRNA splicing is an important component of post-transcriptional gene regulation as variations in the selection of splice sites can alter coding sequence, transcript stability, transcript localization and protein abundance (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Detecting and quantifying isoforms of a given gene can thus quickly inform on possible function and associated regulatory mechanisms. Indeed, gene annotation efforts (e.g. GENCODE, Ensembl) report different isoforms for the vast majority of human genes, yet novel splicing variations are regularly identified when characterizing genes under certain conditions or systems (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>). This indicates that many transcript isoforms remain to be discovered, with some potentially playing key functional roles.</p>
    <p>In normal tissues, tightly regulated splicing programs contribute to specialized tissue or cell type-specific functions (<xref rid="B5" ref-type="bibr">5</xref>). Such dedicated programs have been described in the brain, muscle, epidermis and blood, among other systems. A major hurdle to the identification of additional tissue-specific splicing events is the limited access to cross-tissue analyses and the need to include unannotated splicing variations.</p>
    <p>In contrast to normal splicing variations, disruption of such tissue specific splicing programs has been associated with numerous diseases, cancer in particular (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>). Specifically, splicing disruption is a feature commonly shared between tumor types (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B8" ref-type="bibr">8</xref>) and mutations in proteins controlling splicing can drive oncogenesis (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). On the upside, the abundance of aberrant splicing variations in cancer offers great potential for the development of new therapeutic avenues (<xref rid="B7" ref-type="bibr">7</xref>). The identification of splicing variations as candidate therapeutic targets for a given type of cancer often raises the question about the presence of the same variation in other cancer types.</p>
    <p>Splicing databases are useful tools to interrogate what splicing events occur in what tissues. Available databases come in different forms and address different problems. For example, the GTEx portal (<xref rid="B11" ref-type="bibr">11</xref>) provides exon expression data that can be used to extrapolate what transcript isoforms are used in each of 54 normal tissues. Other resources such as intropolis/Snaptron (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>), VastDB (<xref rid="B14" ref-type="bibr">14</xref>), TSVdb (<xref rid="B15" ref-type="bibr">15</xref>), RJunBase (<xref rid="B16" ref-type="bibr">16</xref>), OncoSplicing (<xref rid="B17" ref-type="bibr">17</xref>), recount3 (<xref rid="B18" ref-type="bibr">18</xref>), MetazExp (<xref rid="B19" ref-type="bibr">19</xref>) and ASCancer Atlas (<xref rid="B20" ref-type="bibr">20</xref>) use different methods to describe splicing variations, using various datasets that can focus on normal human tissues or cancer, or include several species, and may offer a web interface or not (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>).</p>
    <p>Here we present MAJIQlopedia, a database of splicing variations in normal human tissues and cancer. MAJIQlopedia offers two instances, one listing splicing variations found in normal tissues and the second listing variations found in cancer. The normal tissue dataset comprises samples from large-scale projects such as GTEx and BLUEPRINT, but also includes smaller publicly available datasets to provide a comprehensive reference for a total of 86 solid tissue and hematopoietic cell types. The cancer dataset comprises samples from TCGA and Beat-AML as well as pediatric cancer samples from the TARGET and CBTN projects, for a total of 41 cancer cohorts. Compared to existing databases MAJIQlopedia offers several advantages. First is the breadth of the tissue and cancer types included, as described above. Second, its splicing analysis was performed with the MAJIQ algorithm, which has been shown to compare favourably in detection and quantification of alternative splicing (<xref rid="B21" ref-type="bibr">21–23</xref>). MAJIQ formulates alternative splicing as local splicing variations involving splits in a gene's splice graph coming out of or into a reference exon. This allows the MAJIQlopedia to capture complex splicing variations involving more than two splice junctions, as well as unannotated splice sites, junctions, exons and intron retention events (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B21" ref-type="bibr">21</xref>). Such unannotated events are commonly found in cancer (<xref rid="B8" ref-type="bibr">8</xref>). The website optimizes the interface offered by our VOILA module to run quickly on the two very large datasets of cancer and normal samples. The database is accessible online (<ext-link xlink:href="https://majiq.biociphers.org/majiqlopedia/" ext-link-type="uri">https://majiq.biociphers.org/majiqlopedia/</ext-link>) and offers a straightforward query process that facilitates the interrogation of any gene of interest, with a graphical presentation of the data. Users can also request to add data or install their own MAJIQlopedia instance with their data. We used MAJIQlopedia to review cases of known tissue-specific splicing regulation and uncover novel splicing variations in normal tissues and cancer.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>Materials and methods</title>
    <sec id="SEC2-1">
      <title>Datasets</title>
      <p>Seven publicly available datasets were downloaded and processed to generate the normal tissue instance of MAJIQlopedia: GTEx (<xref rid="B24" ref-type="bibr">24</xref>), BLUEPRINT (<xref rid="B25" ref-type="bibr">25</xref>), Leucegene (<xref rid="B26" ref-type="bibr">26</xref>), a T cell sample dataset (<xref rid="B27" ref-type="bibr">27</xref>), a bone sample dataset (<xref rid="B28" ref-type="bibr">28</xref>), a mesenchymal bone marrow dataset (<xref rid="B29" ref-type="bibr">29</xref>) and an osteoblast dataset (<xref rid="B30" ref-type="bibr">30</xref>). These datasets are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>. Four publicly available datasets were downloaded and processed to generate the cancer instance of MAJIQlopedia: TCGA (<xref rid="B31" ref-type="bibr">31</xref>), TARGET (<xref rid="B32" ref-type="bibr">32</xref>), Beat-AML (<xref rid="B33" ref-type="bibr">33</xref>) and CBTN (<xref rid="B34" ref-type="bibr">34</xref>). These datasets are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Data processing</title>
      <p>We limited technical biases by processing all RNA-Seq samples fastq files when possible or by first shuffling bam files and converting to fastq when raw sequencing files were unavailable. Sequencing adapters were trimmed with TrimGalore (v0.6.6) (<xref rid="B35" ref-type="bibr">35</xref>). Reads were aligned with STAR (v2.5.2a) (<xref rid="B36" ref-type="bibr">36</xref>) against the hg38 human genome assembly (<xref rid="B37" ref-type="bibr">37</xref>). Mapped reads were sorted and indexed using samtools (v1.11) (<xref rid="B38" ref-type="bibr">38</xref>). Gene expression quantification was carried out using Salmon (v0.14.0) (<xref rid="B39" ref-type="bibr">39</xref>) in quasi-mapping mode using an index generated with Ensembl GRCh38 transcriptome release 94. Splice junctions were quantified using MAJIQ (v2.2) (<xref rid="B21" ref-type="bibr">21</xref>). MAJIQ defines alternative splicing in terms of local splicing variations (LSVs). For this reason, the same junction can be quantified twice by MAJIQ, i.e. once from the 5′ splice site and once from the 3′ splice site. Duplicate junctions (those that were counted twice) were identified as junctions sharing the exact same coordinates in the same gene. The number of splice junctions given in the text and in the figures correspond to the number of junctions after removing duplicates.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Generation of the MAJIQlopedia data</title>
      <p>Two MAJIQ builds were used to generate MAJIQlopedia, one for normal tissues and one for cancer. The same parameters were used in both cases. Samples belonging to a given tissue or cancer type were grouped together. The MAJIQ build was run using default parameters except for the minimum number of reads required to quantify a junction, which was set at 10 using the --minreads 10 tag. We then applied the MAJIQ PSI and MAJIQ VOILA modules with default parameters to quantify splicing variations.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Protein structure prediction and alignment</title>
      <p>MT1A structures were predicted using ESMFold (<xref rid="B40" ref-type="bibr">40</xref>), and aligned and visualized using the RCSB Protein Database Bank Pairwise Structure Alignment tool (<xref rid="B41" ref-type="bibr">41</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>Results</title>
    <sec id="SEC3-1">
      <title>Generation of MAJIQlopedia</title>
      <p>We assembled publicly available RNA-Seq data from seven sources of normal tissue samples and four sources of cancer samples. Raw sequencing files were re-processed in the same way for all samples to minimize biases and version incompatibility in read alignment methods and reference genome and transcriptome annotations (Figure <xref rid="F1" ref-type="fig">1A</xref>). The quantifications available in MAJIQlopedia represent data from all samples that belong to a certain tissue or cancer type. All tissue types are composed of a minimum of three samples originating from three donors (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1</xref>).</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>MAJIQlopedia content and web interface. (<bold>A</bold>) Strategy used to generate MAJIQlopedia. (<bold>B</bold>) Three simple steps give access to the MAJIQlopedia data for a gene of interest.</p>
        </caption>
        <graphic xlink:href="gkad1043fig1" position="float"/>
      </fig>
      <p>The MAJIQlopedia website allows users to query individual genes through three simple steps, by (i) first choosing whether splicing variations should be shown for normal tissues or cancer, then (ii) entering the name of the gene of interest and finally (iii) visualizing quantifications available for all of the splicing variations that MAJIQ found in our dataset in the selected gene (Figure <xref rid="F1" ref-type="fig">1B</xref>). Quantifications are shown as violin plots and can be downloaded as images. Raw data underlying the generation of these plots are also available as a bulk download for all splice junctions in all tissues from the main page of the website. These data can be used to customize the graphical representation of the data according to the user's need or to perform large-scale analyses across any number of genes.</p>
    </sec>
    <sec id="SEC3-2">
      <title>Summary of the MAJIQlopedia database content</title>
      <p>From 7654 normal and 11 059 cancer samples (Figure <xref rid="F2" ref-type="fig">2A</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1</xref>), we report 210 394 splicing variations totalling 486 175 alternatively used splice junctions in normal tissues and 155 226 splicing variations totalling 338 317 alternatively used splice junctions in cancer. We define variable junctions as junctions involved in a local splicing variation (LSV) event where the junction is used at a minimum of 5% in any tissue. Cancer samples tend to have more unannotated junctions than normal tissues (Figure <xref rid="F2" ref-type="fig">2B</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2</xref>), with splicing variations composed of 20.81% (normal tissues) and 22.98% (cancer) of splice junctions that are unannotated in the Ensembl GRCh38.94 reference transcriptome. The number of alternative splice junctions detected in each tissue ranges from 184 886 (germinal B cells) to 44 293 (mesenchymal bone marrow cells) in normal tissues and 163 580 (high-grade glioma) to 69 032 (diffuse large B-cell lymphoma) in cancer (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2</xref>). These metrics should not be interpreted as a direct measure of the absolute abundance of alternative splicing occurring in a given tissue and should not be compared between tissues because splicing quantifications depend on the read depth of RNA-Seq samples and the number of samples in each tissue/cancer group, which vary between the datasets that we surveyed. Although the database was built separately for normal tissues and cancer, a vast majority of junctions quantified in normal tissues were also found in cancer (Figure <xref rid="F2" ref-type="fig">2C</xref>), making it possible to assess how a given junction is used in both sets.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Overview of the data available in MAJIQlopedia. (<bold>A</bold>) Density plot of the number of samples in each tissue/cancer type. (<bold>B</bold>) Density plot for the relative frequency of unannotated junctions found in normal (grey) and cancer (red) datasets. (<bold>C</bold>) Overlap between variable junctions found in normal tissues and in cancer. (<bold>D</bold>) Number of genes binned by their total number of variable splice junctions in any tissue in normal tissues (left) and cancer (right).</p>
        </caption>
        <graphic xlink:href="gkad1043fig2" position="float"/>
      </fig>
      <p>We next wondered how many variable splice junctions are found in each gene. About a quarter of genes quantified in MAJIQlopedia display little alternative splicing, with fewer than five variable junctions (Figure <xref rid="F2" ref-type="fig">2D</xref>). At the other end of the spectrum, 1550 genes have over 50 variable splice junctions in the context of normal tissues. Many of the genes with the largest number of variable junctions in normal tissues are large genes with numerous exons (e.g. <italic toggle="yes">TTN</italic>, 109.2 kb transcript, 363 annotated exons in MANE transcript; <italic toggle="yes">SYNE2</italic>, 21.8kb transcript and 116 annotated exons in MANE transcript; <italic toggle="yes">HERC1</italic>, 15.2 kb transcript and 78 annotated exons in MANE transcript). Low but measurable levels of intron retention exist in some tissues for these genes, which contributes to the high number of variable junctions reported (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 3A</xref>). When normalizing the number of variable splice junctions by the number of exons in the canonical transcript annotation of protein-coding genes (MANE or Ensembl Canonical transcripts), we find that genes with high levels of splice junction variation display complex splicing patterns. These variations can involve annotated (e.g. <italic toggle="yes">CMC2</italic>, <italic toggle="yes">ZNF655</italic>) or unannotated (e.g. <italic toggle="yes">UBC</italic>, <italic toggle="yes">MRPL43</italic>) splice junctions (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 3B</xref>).</p>
    </sec>
    <sec id="SEC3-3">
      <title>Tissue-regulated splicing variations in MAJIQlopedia</title>
      <p>We sought to illustrate how the quantifications provided in MAJIQlopedia correspond to the splicing patterns expected from the literature for well-known cases of disease-associated alternative splicing events. In the <italic toggle="yes">WT1</italic> gene, skipping of exon 5 is frequent in Wilms tumor, where a common mutation alters the splice donor downstream of exon 5 (<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>). In line with the literature, MAJIQlopedia shows that Wilms tumor samples have lower exon 5 inclusion levels than other cancer types such as acute myeloid leukemia, mesothelioma or ovarian cancer (Figure <xref rid="F3" ref-type="fig">3A</xref>). In the <italic toggle="yes">MAPT</italic> gene, skipping of exon 10 results in the loss of one of four microtubule-binding sequences and the ratio between exon 10 inclusion and skipping likely impacts neurodegeneration in tauopathies (<xref rid="B44" ref-type="bibr">44–46</xref>). Another alternative splicing event in <italic toggle="yes">MAPT</italic> concerns the inclusion of exon 3, which is associated with Parkinsonian disorders (<xref rid="B47" ref-type="bibr">47</xref>). The inclusion of both of these exons varies by brain region (<xref rid="B48" ref-type="bibr">48</xref>,<xref rid="B49" ref-type="bibr">49</xref>). As expected, MAJIQlopedia shows variable inclusion levels between brain regions for both exon 3 and exon 10 (Figure <xref rid="F3" ref-type="fig">3B</xref>). Intriguingly, <italic toggle="yes">MAPT</italic> exons 3 and 10 are also alternatively used in cancer (Figure <xref rid="F3" ref-type="fig">3B</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Visualization of known tissue-specific alternative splicing variations. (<bold>A</bold>) Inclusion levels of an alternative exon in <italic toggle="yes">WT1</italic> are lower in Wilms tumor samples (TARGET-WT) than in testis or in other cancers (Beat-AML, TCGA-MESO, TCGA-OV). (<bold>B</bold>) Two highly variable alternative exons in <italic toggle="yes">MAPT</italic> have tissue- and cancer-specific usage profiles. (<bold>C</bold>) MAJIQlopedia highlights the neural-specific inclusion of exon 7 (green junction) as well as the muscle-specific inclusion of exon 11 (blue junction) in the <italic toggle="yes">BIN1</italic> gene. Shaded boxes were added to highlight brain tissues (top) and muscle (bottom). Additional splicing variations downstream of exon 12 are detailed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4</xref>. Open boxes between exons represent intron retention events. Quantification panels in (A) and (B) were generated from the data available for download on the home page of MAJIQlopedia, while the quantification panels shown in (C) are screenshots of the MAJIQlopedia website. Boxplots (mostly hidden by violin plots) show 25th and 75th percentiles with whiskers at the 5th and 95th percentiles.</p>
        </caption>
        <graphic xlink:href="gkad1043fig3" position="float"/>
      </fig>
      <p>We also looked into normal tissue-specific splicing patterns. The <italic toggle="yes">BIN1</italic> gene is known for differential inclusion of an exon in neural tissues and a separate exon differentially included in muscle (<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B51" ref-type="bibr">51</xref>). Interrogating MAJIQlopedia for <italic toggle="yes">BIN1</italic> allowed us to quickly appreciate how inclusion of BIN exon 7 is restricted to tissues from the nervous system, whereas inclusion of exon 11 is mostly restricted to muscle (Figure <xref rid="F3" ref-type="fig">3C</xref>). Additional known splicing variations involving exons 14–17 are also represented in the database with complex and highly variable splicing patterns in normal tissues (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4A</xref>). Interestingly, we observed that inclusion of the neural exon 7 and inclusion of the muscle exon 11 also occur in neuroblastoma and head and neck cancer, respectively (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4B</xref>). These results are in line with the fact that, while anatomically distinct from the nervous system, neuroblastoma originates from neural cells (<xref rid="B52" ref-type="bibr">52</xref>). As for the inclusion of exon 11 in head and neck cancer (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4B</xref>), this event could reflect the tissue of origin of the cancer, since exon 11 is also included in the salivary gland (Figure <xref rid="F3" ref-type="fig">3C</xref>), albeit at lower levels than in muscle.</p>
    </sec>
    <sec id="SEC3-4">
      <title>Discovery of novel splicing variations</title>
      <p>In order to demonstrate the value of MAJIQlopedia for the identification of novel alternative splicing events, we asked whether splicing variations exist in genes for which only one transcript has been annotated in Ensembl (<xref rid="B53" ref-type="bibr">53</xref>), GENCODE (<xref rid="B54" ref-type="bibr">54</xref>) and RefSeq (<xref rid="B55" ref-type="bibr">55</xref>), and no splicing variations were previously reported. We found such variations in multiple genes, including in <italic toggle="yes">FDX1</italic> and <italic toggle="yes">MEGF9</italic>. The mitochondrial ferredoxin gene <italic toggle="yes">FDX1</italic> is involved in the synthesis of steroid hormones. The gene has four exons but only one annotated transcript. PubMed searches return no publications mentioning alternative splicing or the existence of transcript isoforms in <italic toggle="yes">FDX1</italic>. However, MAJIQlopedia shows that a novel 159nt exon between exons 3 and 4 has inclusion levels of 13% specifically in hematopoietic stem cells (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 5A</xref>). MEGF9 is a putative transmembrane receptor that is developmentally regulated. <italic toggle="yes">MEGF9</italic> has 6 exons and, just like <italic toggle="yes">FDX1</italic>, only one annotated transcript and no publication mentions alternative splicing or multiple isoforms for <italic toggle="yes">MEGF9</italic>. We discovered that alpha-beta CD4+ T cells, monocytes and neutrophils use a novel 123nt exon between exons 2 and 3 of <italic toggle="yes">MEGF9</italic> with inclusion levels of 15% (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 5B</xref>).</p>
      <p>In both cases, the novel exons preserve the reading frame but introduce stop codons in the coding sequence. The <italic toggle="yes">FDX1</italic> exon encodes two consecutive stop codons in the penultimate exon. The fate of the <italic toggle="yes">FDX1</italic> transcript that includes the novel exon is uncertain because transcripts with premature stop codons close to the end of the coding sequence, including in the penultimate exons, can escape nonsense mediated decay (<xref rid="B56" ref-type="bibr">56</xref>). If escaping nonsense mediated decay, this transcript would encode an FDX1 protein isoform lacking the last 13 residues of the 2Fe-2S ferredoxin-type domain. On the other hand, the <italic toggle="yes">MEGF9</italic> exon introduces three stop codons several exons upstream of the last exon. It can be expected that the inclusion of the novel MEGF9 exon renders the transcripts sensitive to nonsense-mediated decay. In line with this assumption, we find that neutrophil and monocyte samples that have high inclusion of the novel exon also have lower <italic toggle="yes">MEGF9</italic> transcript levels (Supplementary Figure 5C). The use of NMD-inducing exons, often referred to as ‘poison exons’, is a known mechanism for regulating gene expression (<xref rid="B57" ref-type="bibr">57</xref>). Whether the novel exon is involved in the regulation of MEGF9 levels will require further investigation.</p>
      <p>We also found a novel splicing event in the metallothionein <italic toggle="yes">MT1A</italic> gene, which is involved in metal detoxification and oxidative stress prediction. We observed that alternative skipping of <italic toggle="yes">MT1A</italic> exon 2 is an isoform that co-exists with the only known transcript at variable levels ranging from 10% to 20% in all solid tissues where the variation is quantified (Figure <xref rid="F4" ref-type="fig">4A</xref>). Skipping of exon 2 preserves the reading frame of the coding sequence, but removes 22aa in the beta domain of the protein (Figure <xref rid="F4" ref-type="fig">4B</xref>). The predicted structure for the skipped isoform aligns well with the canonical isoform and shows that the alpha domain is mostly preserved (Figure <xref rid="F4" ref-type="fig">4B</xref>). The loss of the beta domain would reduce the binding capacity of the protein from seven metal atoms to four and prevent the formation of the supermetalated intermediate MT1A species (<xref rid="B58" ref-type="bibr">58</xref>).</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>Novel alternative splicing events highlighted by MAJIQlopedia. (<bold>A</bold>) A novel cassette exon skipping event (blue junctions) in <italic toggle="yes">MT1A</italic> is used in a large array of tissues. (<bold>B</bold>) The <italic toggle="yes">MT1A</italic> skipping event results in the truncation of the beta domain, but preserves the alpha domain. (<bold>C</bold>) A novel exon inclusion event in the <italic toggle="yes">RPS6KA6</italic> is only found in a pediatric high-grade glioma cohort and a pediatric clear cell sarcoma of the kidney cohort. The splicegraphs at the top show that MAJIQlopedia contains no evidence of alternative splicing in normal tissues, but some variations in cancer, most notably the inclusion of a novel exon between exons 2 and 3. (<bold>D</bold>) Raw reads compiled from 13 samples of clear cell sarcoma of the kidney confirming novel exon inclusion. (<bold>E</bold>) Exon 2a inclusion levels compared to total gene expression of RPS6KA6 in high-grade glioma and clear cell sarcoma of the kidney samples.</p>
        </caption>
        <graphic xlink:href="gkad1043fig4" position="float"/>
      </fig>
      <p>Finally, we wondered if MAJIQlopedia contained information about splicing variations that occur in cancer, but not in normal tissues. There are 822 genes that have at least two alternative splice junctions in at least one cancer type, but no alternative junction used over 5% in any normal tissue. One of those genes is the ribosomal kinase <italic toggle="yes">RPS6KA6</italic> gene, which only has one annotated transcript. In agreement with the literature, no splicing variations are observed in normal tissues. However, MAJIQlopedia shows that there is inclusion of a novel exon between exons 2 and 3 of <italic toggle="yes">RPS6KA6</italic> in pediatric cohorts of high-grade glioma and clear cell sarcoma of the kidney at level of 15% and 25%, respectively (Figure <xref rid="F4" ref-type="fig">4C</xref>). Inspection of raw read alignments confirms the inclusion of the novel exon, labeled as ‘exon 2a’ (Figure <xref rid="F4" ref-type="fig">4D</xref>). While exon 2a shifts the reading frame of the coding sequence and introduces several stop codons, there is no clear relationship between the level of exon 2a inclusion and lower transcript levels in the two cancer cohorts that we looked at (Figure <xref rid="F4" ref-type="fig">4E</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="discussion" id="SEC4">
    <title>Discussion</title>
    <p>In this work, we introduce MAJIQlopedia, a new database with a matching webtool, for exploring splicing variations across normal and cancer samples. Using several examples, we illustrate how MAJIQlopedia can be used to analyze known splicing variations as well as a hypothesis generator, identifying novel splicing variations that are tissue or cancer specific. In addition, users can submit requests to add data or install their own private instance with specific data of interest.</p>
    <p>One caveat of MAJIQlopedia is that it does not include developmental tissues. We hope to address this in future updates as new datasets become available. Another limitation is that we are unable to include sample level information. This limitation is due to data access restrictions and not inherent to the tool as both MAJIQ and the visualization package VOILA can display such information. Another future direction to enhance MAJIQlopedia is to incorporate long-reads and full isoform information. It is also important to note that the information provided in MAJIQlopedia, as for all other splicing databases, is not well suited to perform differential splicing analyses between conditions. For such tests users should instead run MAJIQ directly for conditions of interest and consider running MOCCASIN to correct for unknown or known confounders such as batch effects (<xref rid="B59" ref-type="bibr">59</xref>).</p>
    <p>Overall, we believe that MAJIQlopedia, with its unique set of features, supported datasets, and ease of use, will be of great value to the large community of researchers seeking to understand how the expression of their favorite genes might be regulated and those looking to understand tissue- or cancer-specific splice isoform usage.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkad1043_Supplemental_Files</label>
      <media xlink:href="gkad1043_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>Acknowledgements</title>
    <p>We thank early users of MAJIQlopedia from the Thomas-Tikhonenko, Barash and Lynch labs for the feedback they have provided on the webtool.</p>
  </ack>
  <sec sec-type="data-availability" id="SEC5">
    <title>Data availability</title>
    <p>The data underlying MAJIQlopedia is publicly available, with restricted access in some cases, from the sources listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S2 and S3</xref>.</p>
  </sec>
  <sec id="SEC6">
    <title>Supplementary data</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad1043#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>Funding</title>
    <p>Next Generation of Scientists Award from the Cancer Research Society [990633 to M.Q.V.]; U01 and R01 grants from National Institutes of Health [CA232563 to A.T.T., K.W.L. and Y.B.; LM013437 to Y.B.]. Funding for open access charge: NIH [U01 CA232563].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <notes id="NT1">
    <title>Notes</title>
    <p>Present address: Mathieu Quesnel-Vallières, Department of Immunology and Cell Biology, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.</p>
  </notes>
  <ref-list id="REF1">
    <title>References</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Rio</surname><given-names>D.C.</given-names></string-name></person-group><article-title>Mechanisms and regulation of alternative pre-mRNA splicing</article-title>. <source>Annu. Rev. Biochem.</source><year>2015</year>; <volume>84</volume>:<fpage>291</fpage>–<lpage>323</lpage>.<pub-id pub-id-type="pmid">25784052</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gallego-Paez</surname><given-names>L.M.</given-names></string-name>, <string-name><surname>Bordone</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Leote</surname><given-names>A.C.</given-names></string-name>, <string-name><surname>Saraiva-Agostinho</surname><given-names>N.</given-names></string-name>, <string-name><surname>Ascensão-Ferreira</surname><given-names>M.</given-names></string-name>, <string-name><surname>Barbosa-Morais</surname><given-names>N.L.</given-names></string-name></person-group><article-title>Alternative splicing: the pledge, the turn, and the prestige</article-title>. <source>Hum. Genet.</source><year>2017</year>; <volume>136</volume>:<fpage>1015</fpage>–<lpage>1042</lpage>.<pub-id pub-id-type="pmid">28374191</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Barrera</surname><given-names>A.</given-names></string-name>, <string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>González-Vallinas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Hogenesch</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title>. <source>eLife</source>. <year>2016</year>; <volume>5</volume>:<fpage>e11752</fpage>.<pub-id pub-id-type="pmid">26829591</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aguet</surname><given-names>F.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Castel</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>He</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jo</surname><given-names>B.</given-names></string-name>, <string-name><surname>Mohammadi</surname><given-names>P.</given-names></string-name>, <string-name><surname>Park</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Parsana</surname><given-names>P.</given-names></string-name>, <string-name><surname>Segrè</surname><given-names>A.V.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Genetic effects on gene expression across human tissues</article-title>. <source>Nature</source>. <year>2017</year>; <volume>550</volume>:<fpage>204</fpage>–<lpage>213</lpage>.<pub-id pub-id-type="pmid">29022597</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ule</surname><given-names>J.</given-names></string-name>, <string-name><surname>Blencowe</surname><given-names>B.J.</given-names></string-name></person-group><article-title>Alternative splicing regulatory networks: functions, mechanisms, and evolution</article-title>. <source>Mol. Cell</source>. <year>2019</year>; <volume>76</volume>:<fpage>329</fpage>–<lpage>345</lpage>.<pub-id pub-id-type="pmid">31626751</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>G.-S.</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>T.A.</given-names></string-name></person-group><article-title>Splicing in disease: disruption of the splicing code and the decoding machinery</article-title>. <source>Nat. Rev. Genet.</source><year>2007</year>; <volume>8</volume>:<fpage>749</fpage>–<lpage>761</lpage>.<pub-id pub-id-type="pmid">17726481</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stanley</surname><given-names>R.F.</given-names></string-name>, <string-name><surname>Abdel-Wahab</surname><given-names>O</given-names></string-name></person-group><article-title>Dysregulation and therapeutic targeting of RNA splicing in cancer</article-title>. <source>Nat Cancer</source>. <year>2022</year>; <volume>3</volume>:<fpage>536</fpage>–<lpage>546</lpage>.<pub-id pub-id-type="pmid">35624337</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quesnel-Vallières</surname><given-names>M.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Thomas-Tikhonenko</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>Identifying common transcriptome signatures of cancer by interpreting deep learning models</article-title>. <source>Genome Biol.</source><year>2022</year>; <volume>23</volume>:<fpage>117</fpage>.<pub-id pub-id-type="pmid">35581644</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anczuków</surname><given-names>O.</given-names></string-name>, <string-name><surname>Krainer</surname><given-names>A.R.</given-names></string-name></person-group><article-title>Splicing-factor alterations in cancers</article-title>. <source>RNA</source>. <year>2016</year>; <volume>22</volume>:<fpage>1285</fpage>–<lpage>1301</lpage>.<pub-id pub-id-type="pmid">27530828</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Escobar-Hoyos</surname><given-names>L.</given-names></string-name>, <string-name><surname>Knorr</surname><given-names>K.</given-names></string-name>, <string-name><surname>Abdel-Wahab</surname><given-names>O.</given-names></string-name></person-group><article-title>Aberrant RNA splicing in cancer</article-title>. <source>Annual Review of Cancer Biology</source>. <year>2019</year>; <volume>3</volume>:<fpage>167</fpage>–<lpage>185</lpage>.</mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Consortium</surname><given-names>T.G.T.E.</given-names></string-name>, <string-name><surname>Ardlie</surname><given-names>K.G.</given-names></string-name>, <string-name><surname>Deluca</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Segrè</surname><given-names>A.V.</given-names></string-name>, <string-name><surname>Sullivan</surname><given-names>T.J.</given-names></string-name>, <string-name><surname>Young</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Gelfand</surname><given-names>E.T.</given-names></string-name>, <string-name><surname>Trowbridge</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Maller</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Tukiainen</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title>. <source>Science</source>. <year>2015</year>; <volume>348</volume>:<fpage>648</fpage>–<lpage>660</lpage>.<pub-id pub-id-type="pmid">25954001</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nellore</surname><given-names>A.</given-names></string-name>, <string-name><surname>Jaffe</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Fortin</surname><given-names>J.-P.</given-names></string-name>, <string-name><surname>Alquicira-Hernández</surname><given-names>J.</given-names></string-name>, <string-name><surname>Collado-Torres</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Phillips III</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Karbhari</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hansen</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Langmead</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Human splicing diversity and the extent of unannotated splice junctions across human RNA-seq samples on the Sequence Read Archive</article-title>. <source>Genome Biol.</source><year>2016</year>; <volume>17</volume>:<fpage>266</fpage>.<pub-id pub-id-type="pmid">28038678</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Gaddipati</surname><given-names>P.</given-names></string-name>, <string-name><surname>Nellore</surname><given-names>A.</given-names></string-name>, <string-name><surname>Langmead</surname><given-names>B.</given-names></string-name></person-group><article-title>Snaptron: querying splicing patterns across tens of thousands of RNA-seq samples</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>114</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">28968689</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tapial</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ha</surname><given-names>K.C.H.</given-names></string-name>, <string-name><surname>Sterne-Weiler</surname><given-names>T.</given-names></string-name>, <string-name><surname>Gohr</surname><given-names>A.</given-names></string-name>, <string-name><surname>Braunschweig</surname><given-names>U.</given-names></string-name>, <string-name><surname>Hermoso-Pulido</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quesnel-Vallières</surname><given-names>M.</given-names></string-name>, <string-name><surname>Permanyer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sodaei</surname><given-names>R.</given-names></string-name>, <string-name><surname>Marquez</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms</article-title>. <source>Genome Res.</source><year>2017</year>; <volume>27</volume>:<fpage>1759</fpage>–<lpage>1768</lpage>.<pub-id pub-id-type="pmid">28855263</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>W.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name></person-group><article-title>TSVdb: a web-tool for TCGA splicing variants analysis</article-title>. <source>BMC Genomics</source>. <year>2018</year>; <volume>19</volume>:<fpage>405</fpage>.<pub-id pub-id-type="pmid">29843604</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Meng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Z.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RJunBase: a database of RNA splice junctions in human normal and cancerous tissues</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D201</fpage>–<lpage>D211</lpage>.<pub-id pub-id-type="pmid">33179749</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Tian</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>C.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>50</volume>:<fpage>D1340</fpage>–<lpage>D1347</lpage>.</mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F.Y.</given-names></string-name>, <string-name><surname>Charles</surname><given-names>R.</given-names></string-name>, <string-name><surname>Solomon</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ling</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Imada</surname><given-names>E.L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Joseph</surname><given-names>L.</given-names></string-name>, <string-name><surname>Leek</surname><given-names>J.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>recount3: summaries and queries for large-scale RNA-seq expression and splicing</article-title>. <source>Genome Biol.</source><year>2021</year>; <volume>22</volume>:<fpage>323</fpage>.<pub-id pub-id-type="pmid">34844637</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lang</surname><given-names>K.</given-names></string-name>, <string-name><surname>Jie</surname><given-names>W.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>W.</given-names></string-name></person-group><article-title>MetazExp: a database for gene expression and alternative splicing profiles and their analyses based on 53 615 public RNA-seq samples in 72 metazoan species</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>50</volume>:<fpage>D1046</fpage>–<lpage>D1054</lpage>.</mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zong</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>W.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>P.</given-names></string-name>, <string-name><surname>Li</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>51</volume>:<fpage>D1196</fpage>–<lpage>D1204</lpage>.</mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Aicher</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Jewell</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Radens</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Norton</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>RNA splicing analysis using heterogeneous and large RNA-seq datasets</article-title>. <source>Nat. Commun.</source><year>2023</year>; <volume>14</volume>:<fpage>1230</fpage>.<pub-id pub-id-type="pmid">36869033</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Norton</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>Outlier detection for improved differential splicing quantification from RNA-Seq experiments with replicates</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>1488</fpage>–<lpage>1497</lpage>.<pub-id pub-id-type="pmid">29236961</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mehmood</surname><given-names>A.</given-names></string-name>, <string-name><surname>Laiho</surname><given-names>A.</given-names></string-name>, <string-name><surname>Venäläinen</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>McGlinchey</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>N.</given-names></string-name>, <string-name><surname>Elo</surname><given-names>L.L.</given-names></string-name></person-group><article-title>Systematic evaluation of differential splicing tools for RNA-seq studies</article-title>. <source>Briefings Bioinf.</source><year>2020</year>; <volume>21</volume>:<fpage>2052</fpage>–<lpage>2065</lpage>.</mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lonsdale</surname><given-names>J.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Salvatore</surname><given-names>M.</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lo</surname><given-names>E.</given-names></string-name>, <string-name><surname>Shad</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hasz</surname><given-names>R.</given-names></string-name>, <string-name><surname>Walters</surname><given-names>G.</given-names></string-name>, <string-name><surname>Garcia</surname><given-names>F.</given-names></string-name>, <string-name><surname>Young</surname><given-names>N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Genotype-Tissue Expression (GTEx) project</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>580</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">23715323</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adams</surname><given-names>D.</given-names></string-name>, <string-name><surname>Altucci</surname><given-names>L.</given-names></string-name>, <string-name><surname>Antonarakis</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Ballesteros</surname><given-names>J.</given-names></string-name>, <string-name><surname>Beck</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bird</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bock</surname><given-names>C.</given-names></string-name>, <string-name><surname>Boehm</surname><given-names>B.</given-names></string-name>, <string-name><surname>Campo</surname><given-names>E.</given-names></string-name>, <string-name><surname>Caricasole</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>BLUEPRINT to decode the epigenetic signature written in blood</article-title>. <source>Nat. Biotechnol.</source><year>2012</year>; <volume>30</volume>:<fpage>224</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">22398613</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacRae</surname><given-names>T.</given-names></string-name>, <string-name><surname>Sargeant</surname><given-names>T.</given-names></string-name>, <string-name><surname>Lemieux</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hébert</surname><given-names>J.</given-names></string-name>, <string-name><surname>Deneault</surname><given-names>É.</given-names></string-name>, <string-name><surname>Sauvageau</surname><given-names>G.</given-names></string-name></person-group><article-title>RNA-Seq reveals spliceosome and proteasome genes as most consistent transcripts in human cancer cells</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e72884</fpage>.<pub-id pub-id-type="pmid">24069164</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ranzani</surname><given-names>V.</given-names></string-name>, <string-name><surname>Rossetti</surname><given-names>G.</given-names></string-name>, <string-name><surname>Panzeri</surname><given-names>I.</given-names></string-name>, <string-name><surname>Arrigoni</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bonnal</surname><given-names>R.J.P.</given-names></string-name>, <string-name><surname>Curti</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gruarin</surname><given-names>P.</given-names></string-name>, <string-name><surname>Provasi</surname><given-names>E.</given-names></string-name>, <string-name><surname>Sugliano</surname><given-names>E.</given-names></string-name>, <string-name><surname>Marconi</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4</article-title>. <source>Nat. Immunol.</source><year>2015</year>; <volume>16</volume>:<fpage>318</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">25621826</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scott</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Temiz</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Sarver</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>LaRue</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Rathe</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Varshney</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Moriarity</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>O’Brien</surname><given-names>T.D.</given-names></string-name>, <string-name><surname>Spector</surname><given-names>L.G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Comparative transcriptome analysis quantifies immune cell transcript levels, metastatic progression, and survival in osteosarcoma</article-title>. <source>Cancer Res.</source><year>2018</year>; <volume>78</volume>:<fpage>326</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">29066513</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.-W.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>W.-Y.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>F.-J.</given-names></string-name>, <string-name><surname>Luo</surname><given-names>C.-W.</given-names></string-name></person-group><article-title>Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis</article-title>. <source>Cell Commun. Signal.</source><year>2022</year>; <volume>20</volume>:<fpage>190</fpage>.<pub-id pub-id-type="pmid">36443839</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moriarity</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>Otto</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Rahrmann</surname><given-names>E.P.</given-names></string-name>, <string-name><surname>Rathe</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Weg</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Manlove</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>LaRue</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Temiz</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Molyneux</surname><given-names>S.D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis</article-title>. <source>Nat. Genet.</source><year>2015</year>; <volume>47</volume>:<fpage>615</fpage>–<lpage>624</lpage>.<pub-id pub-id-type="pmid">25961939</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weinstein</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Collisson</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Mills</surname><given-names>G.B.</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>K.R.M.</given-names></string-name>, <string-name><surname>Ozenberger</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Ellrott</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shmulevich</surname><given-names>I.</given-names></string-name>, <string-name><surname>Sander</surname><given-names>C.</given-names></string-name>, <string-name><surname>Stuart</surname><given-names>J.M.</given-names></string-name></person-group><article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>1113</fpage>–<lpage>1120</lpage>.<pub-id pub-id-type="pmid">24071849</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname><given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Alexandrov</surname><given-names>L.B.</given-names></string-name>, <string-name><surname>Edmonson</surname><given-names>M.N.</given-names></string-name>, <string-name><surname>Gawad</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Rusch</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Easton</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours</article-title>. <source>Nature</source>. <year>2018</year>; <volume>555</volume>:<fpage>371</fpage>–<lpage>376</lpage>.<pub-id pub-id-type="pmid">29489755</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tyner</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Tognon</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Bottomly</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wilmot</surname><given-names>B.</given-names></string-name>, <string-name><surname>Kurtz</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Savage</surname><given-names>S.L.</given-names></string-name>, <string-name><surname>Long</surname><given-names>N.</given-names></string-name>, <string-name><surname>Schultz</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Traer</surname><given-names>E.</given-names></string-name>, <string-name><surname>Abel</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Functional genomic landscape of acute myeloid leukaemia</article-title>. <source>Nature</source>. <year>2018</year>; <volume>562</volume>:<fpage>526</fpage>–<lpage>531</lpage>.<pub-id pub-id-type="pmid">30333627</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lilly</surname><given-names>J.V.</given-names></string-name>, <string-name><surname>Rokita</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Mason</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Patton</surname><given-names>T.</given-names></string-name>, <string-name><surname>Stefankiewiz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Higgins</surname><given-names>D.</given-names></string-name>, <string-name><surname>Trooskin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Larouci</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Arya</surname><given-names>K.</given-names></string-name>, <string-name><surname>Appert</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science</article-title>. <source>Neoplasia</source>. <year>2022</year>; <volume>35</volume>:<fpage>100846</fpage>.<pub-id pub-id-type="pmid">36335802</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krueger</surname><given-names>F.</given-names></string-name>, <string-name><surname>James</surname><given-names>F.</given-names></string-name>, <string-name><surname>Ewels</surname><given-names>P.</given-names></string-name>, <string-name><surname>Afyounian</surname><given-names>E.</given-names></string-name>, <string-name><surname>Weinstein</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schuster-Boeckler</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hulselmans</surname><given-names>G.</given-names></string-name><collab>sclamons</collab></person-group><article-title>FelixKrueger/TrimGalore: v0.6.10 - add default decompression path</article-title>. <source>Zenodo</source>. <year>2023</year>; <pub-id pub-id-type="doi">10.5281/zenodo.7598955</pub-id>.</mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Schlesinger</surname><given-names>F.</given-names></string-name>, <string-name><surname>Drenkow</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zaleski</surname><given-names>C.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>S.</given-names></string-name>, <string-name><surname>Batut</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chaisson</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gingeras</surname><given-names>T.R.</given-names></string-name></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>15</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hubbard</surname><given-names>T.</given-names></string-name>, <string-name><surname>Barker</surname><given-names>D.</given-names></string-name>, <string-name><surname>Birney</surname><given-names>E.</given-names></string-name>, <string-name><surname>Cameron</surname><given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cox</surname><given-names>T.</given-names></string-name>, <string-name><surname>Cuff</surname><given-names>J.</given-names></string-name>, <string-name><surname>Curwen</surname><given-names>V.</given-names></string-name>, <string-name><surname>Down</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Ensembl genome database project</article-title>. <source>Nucleic Acids Res.</source><year>2002</year>; <volume>30</volume>:<fpage>38</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">11752248</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>1000 Genome Project Data Processing Subgroup</collab><string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Handsaker</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wysoker</surname><given-names>A.</given-names></string-name>, <string-name><surname>Fennell</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Homer</surname><given-names>N.</given-names></string-name>, <string-name><surname>Marth</surname><given-names>G.</given-names></string-name>, <string-name><surname>Abecasis</surname><given-names>G.</given-names></string-name>, <string-name><surname>Durbin</surname><given-names>R.</given-names></string-name></person-group><article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>2078</fpage>–<lpage>2079</lpage>.<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Patro</surname><given-names>R.</given-names></string-name>, <string-name><surname>Duggal</surname><given-names>G.</given-names></string-name>, <string-name><surname>Love</surname><given-names>M.I.</given-names></string-name>, <string-name><surname>Irizarry</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Kingsford</surname><given-names>C.</given-names></string-name></person-group><article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title>. <source>Nat. Methods</source>. <year>2017</year>; <volume>14</volume>:<fpage>417</fpage>–<lpage>419</lpage>.<pub-id pub-id-type="pmid">28263959</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Akin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Rao</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hie</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>W.</given-names></string-name>, <string-name><surname>Smetanin</surname><given-names>N.</given-names></string-name>, <string-name><surname>Verkuil</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kabeli</surname><given-names>O.</given-names></string-name>, <string-name><surname>Shmueli</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Evolutionary-scale prediction of atomic-level protein structure with a language model</article-title>. <source>Science</source>. <year>2023</year>; <volume>379</volume>:<fpage>1123</fpage>–<lpage>1130</lpage>.<pub-id pub-id-type="pmid">36927031</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berman</surname><given-names>H.M.</given-names></string-name>, <string-name><surname>Westbrook</surname><given-names>J.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Gilliland</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bhat</surname><given-names>T.N.</given-names></string-name>, <string-name><surname>Weissig</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shindyalov</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Bourne</surname><given-names>P.E.</given-names></string-name></person-group><article-title>The Protein Data Bank</article-title>. <source>Nucleic Acids Res.</source><year>2000</year>; <volume>28</volume>:<fpage>235</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Simms</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>Algar</surname><given-names>E.M.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>P.J.</given-names></string-name></person-group><article-title>Splicing of exon 5 in the WT1 gene is disrupted in Wilms’ tumour</article-title>. <source>Eur. J. Cancer</source>. <year>1995</year>; <volume>31</volume>:<fpage>2270</fpage>–<lpage>2276</lpage>.</mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schneider</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wildhardt</surname><given-names>G.</given-names></string-name>, <string-name><surname>Ludwig</surname><given-names>R.</given-names></string-name>, <string-name><surname>Royer-Pokora</surname><given-names>B.</given-names></string-name></person-group><article-title>Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms’ tumor and severe genital malformations</article-title>. <source>Hum. Genet.</source><year>1993</year>; <volume>91</volume>:<fpage>599</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="pmid">8393425</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hernández</surname><given-names>F.</given-names></string-name>, <string-name><surname>Pérez</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lucas</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Mata</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Bhat</surname><given-names>R.</given-names></string-name>, <string-name><surname>Avila</surname><given-names>J.</given-names></string-name></person-group><article-title>Glycogen synthase kinase-3 plays a crucial role in Tau exon 10 splicing and intranuclear distribution of SC35: implications for Alzheimer's disease</article-title>. <source>J. Biol. Chem.</source><year>2004</year>; <volume>279</volume>:<fpage>3801</fpage>–<lpage>3806</lpage>.<pub-id pub-id-type="pmid">14602710</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name></person-group><article-title>Alternative splicing: human disease and quantitative analysis from high-throughput sequencing</article-title>. <source>Comput. Struct. Biotechnol. J.</source><year>2020</year>; <volume>19</volume>:<fpage>183</fpage>–<lpage>195</lpage>.<pub-id pub-id-type="pmid">33425250</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>F.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>C.-X.</given-names></string-name></person-group><article-title>Tau exon 10 alternative splicing and tauopathies</article-title>. <source>Mol. Neurodegener.</source><year>2008</year>; <volume>3</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">18616804</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lai</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Bechy</surname><given-names>A.-L.</given-names></string-name>, <string-name><surname>Denk</surname><given-names>F.</given-names></string-name>, <string-name><surname>Collins</surname><given-names>E.</given-names></string-name>, <string-name><surname>Gavriliouk</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zaugg</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Ryan</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Wade-Martins</surname><given-names>R.</given-names></string-name>, <string-name><surname>Caffrey</surname><given-names>T.M.</given-names></string-name></person-group><article-title>Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders</article-title>. <source>Mol.r Neurodegener.</source><year>2017</year>; <volume>12</volume>:<fpage>79</fpage>.</mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trabzuni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wray</surname><given-names>S.</given-names></string-name>, <string-name><surname>Vandrovcova</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ramasamy</surname><given-names>A.</given-names></string-name>, <string-name><surname>Walker</surname><given-names>R.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>C.</given-names></string-name>, <string-name><surname>Luk</surname><given-names>C.</given-names></string-name>, <string-name><surname>Gibbs</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Dillman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hernandez</surname><given-names>D.G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies</article-title>. <source>Hum. Mol. Genet.</source><year>2012</year>; <volume>21</volume>:<fpage>4094</fpage>–<lpage>4103</lpage>.<pub-id pub-id-type="pmid">22723018</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corsi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bombieri</surname><given-names>C.</given-names></string-name>, <string-name><surname>Valenti</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Romanelli</surname><given-names>M.G.</given-names></string-name></person-group><article-title>Tau Isoforms: gaining Insight into MAPT Alternative Splicing</article-title>. <source>Int. J. Mol. Sci.</source><year>2022</year>; <volume>23</volume>:<fpage>15383</fpage>.<pub-id pub-id-type="pmid">36499709</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>In silico to in vivo splicing analysis using splicing code models</article-title>. <source>Methods</source>. <year>2014</year>; <volume>67</volume>:<fpage>3</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">24321485</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Nagel</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Fagg</surname><given-names>W.S.</given-names></string-name>, <string-name><surname>Shiue</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cline</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Perriman</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Donohue</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Ares</surname><given-names>M.</given-names></string-name></person-group><article-title>Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation</article-title>. <source>RNA</source>. <year>2013</year>; <volume>19</volume>:<fpage>627</fpage>–<lpage>638</lpage>.<pub-id pub-id-type="pmid">23525800</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnsen</surname><given-names>J.I.</given-names></string-name>, <string-name><surname>Dyberg</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wickström</surname><given-names>M.</given-names></string-name></person-group><article-title>Neuroblastoma—a neural crest derived embryonal malignancy</article-title>. <source>Front. Mol. Neurosci.</source><year>2019</year>; <volume>12</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">30760980</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cunningham</surname><given-names>F.</given-names></string-name>, <string-name><surname>Allen</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Allen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Alvarez-Jarreta</surname><given-names>J.</given-names></string-name>, <string-name><surname>Amode</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Armean</surname><given-names>I.M.</given-names></string-name>, <string-name><surname>Austine-Orimoloye</surname><given-names>O.</given-names></string-name>, <string-name><surname>Azov</surname><given-names>A.G.</given-names></string-name>, <string-name><surname>Barnes</surname><given-names>I.</given-names></string-name>, <string-name><surname>Bennett</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Ensembl 2022</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D988</fpage>–<lpage>D995</lpage>.<pub-id pub-id-type="pmid">34791404</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frankish</surname><given-names>A.</given-names></string-name>, <string-name><surname>Diekhans</surname><given-names>M.</given-names></string-name>, <string-name><surname>Jungreis</surname><given-names>I.</given-names></string-name>, <string-name><surname>Lagarde</surname><given-names>J.</given-names></string-name>, <string-name><surname>Loveland</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Mudge</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Sisu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Armstrong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Barnes</surname><given-names>I.</given-names></string-name><etal>et al</etal>.</person-group><article-title>GENCODE 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D916</fpage>–<lpage>D923</lpage>.<pub-id pub-id-type="pmid">33270111</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Leary</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>M.W.</given-names></string-name>, <string-name><surname>Brister</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Ciufo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Haddad</surname><given-names>D.</given-names></string-name>, <string-name><surname>McVeigh</surname><given-names>R.</given-names></string-name>, <string-name><surname>Rajput</surname><given-names>B.</given-names></string-name>, <string-name><surname>Robbertse</surname><given-names>B.</given-names></string-name>, <string-name><surname>Smith-White</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ako-Adjei</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D733</fpage>–<lpage>D745</lpage>.<pub-id pub-id-type="pmid">26553804</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Supek</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lehner</surname><given-names>B.</given-names></string-name>, <string-name><surname>Lindeboom</surname><given-names>R.G.H.</given-names></string-name></person-group><article-title>To NMD or not to NMD: nonsense-mediated mRNA decay in cancer and other genetic diseases</article-title>. <source>Trends Genet.</source><year>2021</year>; <volume>37</volume>:<fpage>657</fpage>–<lpage>668</lpage>.<pub-id pub-id-type="pmid">33277042</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leclair</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Brugiolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Urbanski</surname><given-names>L.</given-names></string-name>, <string-name><surname>Lawson</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Thakar</surname><given-names>K.</given-names></string-name>, <string-name><surname>Yurieva</surname><given-names>M.</given-names></string-name>, <string-name><surname>George</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hinson</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>A.</given-names></string-name>, <string-name><surname>Graveley</surname><given-names>B.R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Poison exon splicing regulates a coordinated network of SR protein expression during differentiation and tumorigenesis</article-title>. <source>Mol. Cell</source>. <year>2020</year>; <volume>80</volume>:<fpage>648</fpage>–<lpage>665</lpage>.<pub-id pub-id-type="pmid">33176162</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sutherland</surname><given-names>D.E.K.</given-names></string-name>, <string-name><surname>Willans</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Stillman</surname><given-names>M.J.</given-names></string-name></person-group><article-title>Single domain metallothioneins: supermetalation of human MT 1a</article-title>. <source>J. Am. Chem. Soc.</source><year>2012</year>; <volume>134</volume>:<fpage>3290</fpage>–<lpage>3299</lpage>.<pub-id pub-id-type="pmid">22242602</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Slaff</surname><given-names>B.</given-names></string-name>, <string-name><surname>Radens</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Jewell</surname><given-names>P.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Thomas-Tikhonenko</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>MOCCASIN: a method for correcting for known and unknown confounders in RNA splicing analysis</article-title>. <source>Nat. Commun.</source><year>2021</year>; <volume>12</volume>:<fpage>3353</fpage>.<pub-id pub-id-type="pmid">34099673</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10767883</article-id>
    <article-id pub-id-type="pmid">37953365</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkad1043</article-id>
    <article-id pub-id-type="publisher-id">gkad1043</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MAJIQlopedia: an encyclopedia of RNA splicing variations in human tissues and cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9945-8123</contrib-id>
        <name>
          <surname>Quesnel-Vallières</surname>
          <given-names>Mathieu</given-names>
        </name>
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Biochemistry and Biophysics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jewell</surname>
          <given-names>San</given-names>
        </name>
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0120-8079</contrib-id>
        <name>
          <surname>Lynch</surname>
          <given-names>Kristen W</given-names>
        </name>
        <aff><institution>Department of Biochemistry and Biophysics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2739-2206</contrib-id>
        <name>
          <surname>Thomas-Tikhonenko</surname>
          <given-names>Andrei</given-names>
        </name>
        <aff><institution>Division of Cancer Pathobiology, Children's Hospital of Philadelphia</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Division of Oncology, Children's Hospital of Philadelphia</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Pathology &amp; Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Barash</surname>
          <given-names>Yoseph</given-names>
        </name>
        <!--yosephb@seas.upenn.edu-->
        <aff><institution>Department of Genetics, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, PA <addr-line>19104</addr-line>, <country country="US">USA</country></aff>
        <aff><institution>Department of Computer and Information Science, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, <addr-line>PA</addr-line>, <country country="US">USA</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 215 746 8683; Email: <email>yosephb@seas.upenn.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>05</day>
      <month>1</month>
      <year>2024</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-11-11">
      <day>11</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>11</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <volume>52</volume>
    <issue>D1</issue>
    <fpage>D213</fpage>
    <lpage>D221</lpage>
    <history>
      <date date-type="accepted">
        <day>02</day>
        <month>11</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>11</day>
        <month>10</month>
        <year>2023</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2024</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkad1043.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Quantification of RNA splicing variations based on RNA-Sequencing can reveal tissue- and disease-specific splicing patterns. To study such splicing variations, we introduce MAJIQlopedia, an encyclopedia of splicing variations that encompasses 86 human tissues and 41 cancer datasets. MAJIQlopedia reports annotated and unannotated splicing events for a total of 486 175 alternative splice junctions in normal tissues and 338 317 alternative splice junctions in cancer. This database, available at <ext-link xlink:href="https://majiq.biociphers.org/majiqlopedia/" ext-link-type="uri">https://majiq.biociphers.org/majiqlopedia/</ext-link>, includes a user-friendly interface that provides graphical representations of junction usage quantification for each junction across all tissue or cancer types. To demonstrate case usage of MAJIQlopedia, we review splicing variations in genes <italic toggle="yes">WT1</italic>, <italic toggle="yes">MAPT</italic> and <italic toggle="yes">BIN1</italic>, which all have known tissue or cancer-specific splicing variations. We also use MAJIQlopedia to highlight novel splicing variations in <italic toggle="yes">FDX1</italic> and <italic toggle="yes">MEGF9</italic> in normal tissues, and we uncover a novel exon inclusion event in <italic toggle="yes">RPS6KA6</italic> that only occurs in two cancer types. Users can download the database, request the addition of data to the webtool, or install a MAJIQlopedia server to integrate proprietary data. MAJIQlopedia can serve as a reference database for researchers seeking to understand what splicing variations exist in genes of interest, and those looking to understand tissue- or cancer-specific splice isoform usage.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <graphic xlink:href="gkad1043figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Cancer Research Society</institution>
            <institution-id institution-id-type="DOI">10.13039/100009326</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>990633</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>CA232563</award-id>
        <award-id>LM013437</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>Introduction</title>
    <p>Alternative pre-mRNA splicing is an important component of post-transcriptional gene regulation as variations in the selection of splice sites can alter coding sequence, transcript stability, transcript localization and protein abundance (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Detecting and quantifying isoforms of a given gene can thus quickly inform on possible function and associated regulatory mechanisms. Indeed, gene annotation efforts (e.g. GENCODE, Ensembl) report different isoforms for the vast majority of human genes, yet novel splicing variations are regularly identified when characterizing genes under certain conditions or systems (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>). This indicates that many transcript isoforms remain to be discovered, with some potentially playing key functional roles.</p>
    <p>In normal tissues, tightly regulated splicing programs contribute to specialized tissue or cell type-specific functions (<xref rid="B5" ref-type="bibr">5</xref>). Such dedicated programs have been described in the brain, muscle, epidermis and blood, among other systems. A major hurdle to the identification of additional tissue-specific splicing events is the limited access to cross-tissue analyses and the need to include unannotated splicing variations.</p>
    <p>In contrast to normal splicing variations, disruption of such tissue specific splicing programs has been associated with numerous diseases, cancer in particular (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>). Specifically, splicing disruption is a feature commonly shared between tumor types (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B8" ref-type="bibr">8</xref>) and mutations in proteins controlling splicing can drive oncogenesis (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). On the upside, the abundance of aberrant splicing variations in cancer offers great potential for the development of new therapeutic avenues (<xref rid="B7" ref-type="bibr">7</xref>). The identification of splicing variations as candidate therapeutic targets for a given type of cancer often raises the question about the presence of the same variation in other cancer types.</p>
    <p>Splicing databases are useful tools to interrogate what splicing events occur in what tissues. Available databases come in different forms and address different problems. For example, the GTEx portal (<xref rid="B11" ref-type="bibr">11</xref>) provides exon expression data that can be used to extrapolate what transcript isoforms are used in each of 54 normal tissues. Other resources such as intropolis/Snaptron (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>), VastDB (<xref rid="B14" ref-type="bibr">14</xref>), TSVdb (<xref rid="B15" ref-type="bibr">15</xref>), RJunBase (<xref rid="B16" ref-type="bibr">16</xref>), OncoSplicing (<xref rid="B17" ref-type="bibr">17</xref>), recount3 (<xref rid="B18" ref-type="bibr">18</xref>), MetazExp (<xref rid="B19" ref-type="bibr">19</xref>) and ASCancer Atlas (<xref rid="B20" ref-type="bibr">20</xref>) use different methods to describe splicing variations, using various datasets that can focus on normal human tissues or cancer, or include several species, and may offer a web interface or not (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>).</p>
    <p>Here we present MAJIQlopedia, a database of splicing variations in normal human tissues and cancer. MAJIQlopedia offers two instances, one listing splicing variations found in normal tissues and the second listing variations found in cancer. The normal tissue dataset comprises samples from large-scale projects such as GTEx and BLUEPRINT, but also includes smaller publicly available datasets to provide a comprehensive reference for a total of 86 solid tissue and hematopoietic cell types. The cancer dataset comprises samples from TCGA and Beat-AML as well as pediatric cancer samples from the TARGET and CBTN projects, for a total of 41 cancer cohorts. Compared to existing databases MAJIQlopedia offers several advantages. First is the breadth of the tissue and cancer types included, as described above. Second, its splicing analysis was performed with the MAJIQ algorithm, which has been shown to compare favourably in detection and quantification of alternative splicing (<xref rid="B21" ref-type="bibr">21–23</xref>). MAJIQ formulates alternative splicing as local splicing variations involving splits in a gene's splice graph coming out of or into a reference exon. This allows the MAJIQlopedia to capture complex splicing variations involving more than two splice junctions, as well as unannotated splice sites, junctions, exons and intron retention events (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B21" ref-type="bibr">21</xref>). Such unannotated events are commonly found in cancer (<xref rid="B8" ref-type="bibr">8</xref>). The website optimizes the interface offered by our VOILA module to run quickly on the two very large datasets of cancer and normal samples. The database is accessible online (<ext-link xlink:href="https://majiq.biociphers.org/majiqlopedia/" ext-link-type="uri">https://majiq.biociphers.org/majiqlopedia/</ext-link>) and offers a straightforward query process that facilitates the interrogation of any gene of interest, with a graphical presentation of the data. Users can also request to add data or install their own MAJIQlopedia instance with their data. We used MAJIQlopedia to review cases of known tissue-specific splicing regulation and uncover novel splicing variations in normal tissues and cancer.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>Materials and methods</title>
    <sec id="SEC2-1">
      <title>Datasets</title>
      <p>Seven publicly available datasets were downloaded and processed to generate the normal tissue instance of MAJIQlopedia: GTEx (<xref rid="B24" ref-type="bibr">24</xref>), BLUEPRINT (<xref rid="B25" ref-type="bibr">25</xref>), Leucegene (<xref rid="B26" ref-type="bibr">26</xref>), a T cell sample dataset (<xref rid="B27" ref-type="bibr">27</xref>), a bone sample dataset (<xref rid="B28" ref-type="bibr">28</xref>), a mesenchymal bone marrow dataset (<xref rid="B29" ref-type="bibr">29</xref>) and an osteoblast dataset (<xref rid="B30" ref-type="bibr">30</xref>). These datasets are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>. Four publicly available datasets were downloaded and processed to generate the cancer instance of MAJIQlopedia: TCGA (<xref rid="B31" ref-type="bibr">31</xref>), TARGET (<xref rid="B32" ref-type="bibr">32</xref>), Beat-AML (<xref rid="B33" ref-type="bibr">33</xref>) and CBTN (<xref rid="B34" ref-type="bibr">34</xref>). These datasets are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Data processing</title>
      <p>We limited technical biases by processing all RNA-Seq samples fastq files when possible or by first shuffling bam files and converting to fastq when raw sequencing files were unavailable. Sequencing adapters were trimmed with TrimGalore (v0.6.6) (<xref rid="B35" ref-type="bibr">35</xref>). Reads were aligned with STAR (v2.5.2a) (<xref rid="B36" ref-type="bibr">36</xref>) against the hg38 human genome assembly (<xref rid="B37" ref-type="bibr">37</xref>). Mapped reads were sorted and indexed using samtools (v1.11) (<xref rid="B38" ref-type="bibr">38</xref>). Gene expression quantification was carried out using Salmon (v0.14.0) (<xref rid="B39" ref-type="bibr">39</xref>) in quasi-mapping mode using an index generated with Ensembl GRCh38 transcriptome release 94. Splice junctions were quantified using MAJIQ (v2.2) (<xref rid="B21" ref-type="bibr">21</xref>). MAJIQ defines alternative splicing in terms of local splicing variations (LSVs). For this reason, the same junction can be quantified twice by MAJIQ, i.e. once from the 5′ splice site and once from the 3′ splice site. Duplicate junctions (those that were counted twice) were identified as junctions sharing the exact same coordinates in the same gene. The number of splice junctions given in the text and in the figures correspond to the number of junctions after removing duplicates.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Generation of the MAJIQlopedia data</title>
      <p>Two MAJIQ builds were used to generate MAJIQlopedia, one for normal tissues and one for cancer. The same parameters were used in both cases. Samples belonging to a given tissue or cancer type were grouped together. The MAJIQ build was run using default parameters except for the minimum number of reads required to quantify a junction, which was set at 10 using the --minreads 10 tag. We then applied the MAJIQ PSI and MAJIQ VOILA modules with default parameters to quantify splicing variations.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Protein structure prediction and alignment</title>
      <p>MT1A structures were predicted using ESMFold (<xref rid="B40" ref-type="bibr">40</xref>), and aligned and visualized using the RCSB Protein Database Bank Pairwise Structure Alignment tool (<xref rid="B41" ref-type="bibr">41</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>Results</title>
    <sec id="SEC3-1">
      <title>Generation of MAJIQlopedia</title>
      <p>We assembled publicly available RNA-Seq data from seven sources of normal tissue samples and four sources of cancer samples. Raw sequencing files were re-processed in the same way for all samples to minimize biases and version incompatibility in read alignment methods and reference genome and transcriptome annotations (Figure <xref rid="F1" ref-type="fig">1A</xref>). The quantifications available in MAJIQlopedia represent data from all samples that belong to a certain tissue or cancer type. All tissue types are composed of a minimum of three samples originating from three donors (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1</xref>).</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>MAJIQlopedia content and web interface. (<bold>A</bold>) Strategy used to generate MAJIQlopedia. (<bold>B</bold>) Three simple steps give access to the MAJIQlopedia data for a gene of interest.</p>
        </caption>
        <graphic xlink:href="gkad1043fig1" position="float"/>
      </fig>
      <p>The MAJIQlopedia website allows users to query individual genes through three simple steps, by (i) first choosing whether splicing variations should be shown for normal tissues or cancer, then (ii) entering the name of the gene of interest and finally (iii) visualizing quantifications available for all of the splicing variations that MAJIQ found in our dataset in the selected gene (Figure <xref rid="F1" ref-type="fig">1B</xref>). Quantifications are shown as violin plots and can be downloaded as images. Raw data underlying the generation of these plots are also available as a bulk download for all splice junctions in all tissues from the main page of the website. These data can be used to customize the graphical representation of the data according to the user's need or to perform large-scale analyses across any number of genes.</p>
    </sec>
    <sec id="SEC3-2">
      <title>Summary of the MAJIQlopedia database content</title>
      <p>From 7654 normal and 11 059 cancer samples (Figure <xref rid="F2" ref-type="fig">2A</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1</xref>), we report 210 394 splicing variations totalling 486 175 alternatively used splice junctions in normal tissues and 155 226 splicing variations totalling 338 317 alternatively used splice junctions in cancer. We define variable junctions as junctions involved in a local splicing variation (LSV) event where the junction is used at a minimum of 5% in any tissue. Cancer samples tend to have more unannotated junctions than normal tissues (Figure <xref rid="F2" ref-type="fig">2B</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2</xref>), with splicing variations composed of 20.81% (normal tissues) and 22.98% (cancer) of splice junctions that are unannotated in the Ensembl GRCh38.94 reference transcriptome. The number of alternative splice junctions detected in each tissue ranges from 184 886 (germinal B cells) to 44 293 (mesenchymal bone marrow cells) in normal tissues and 163 580 (high-grade glioma) to 69 032 (diffuse large B-cell lymphoma) in cancer (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2</xref>). These metrics should not be interpreted as a direct measure of the absolute abundance of alternative splicing occurring in a given tissue and should not be compared between tissues because splicing quantifications depend on the read depth of RNA-Seq samples and the number of samples in each tissue/cancer group, which vary between the datasets that we surveyed. Although the database was built separately for normal tissues and cancer, a vast majority of junctions quantified in normal tissues were also found in cancer (Figure <xref rid="F2" ref-type="fig">2C</xref>), making it possible to assess how a given junction is used in both sets.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Overview of the data available in MAJIQlopedia. (<bold>A</bold>) Density plot of the number of samples in each tissue/cancer type. (<bold>B</bold>) Density plot for the relative frequency of unannotated junctions found in normal (grey) and cancer (red) datasets. (<bold>C</bold>) Overlap between variable junctions found in normal tissues and in cancer. (<bold>D</bold>) Number of genes binned by their total number of variable splice junctions in any tissue in normal tissues (left) and cancer (right).</p>
        </caption>
        <graphic xlink:href="gkad1043fig2" position="float"/>
      </fig>
      <p>We next wondered how many variable splice junctions are found in each gene. About a quarter of genes quantified in MAJIQlopedia display little alternative splicing, with fewer than five variable junctions (Figure <xref rid="F2" ref-type="fig">2D</xref>). At the other end of the spectrum, 1550 genes have over 50 variable splice junctions in the context of normal tissues. Many of the genes with the largest number of variable junctions in normal tissues are large genes with numerous exons (e.g. <italic toggle="yes">TTN</italic>, 109.2 kb transcript, 363 annotated exons in MANE transcript; <italic toggle="yes">SYNE2</italic>, 21.8kb transcript and 116 annotated exons in MANE transcript; <italic toggle="yes">HERC1</italic>, 15.2 kb transcript and 78 annotated exons in MANE transcript). Low but measurable levels of intron retention exist in some tissues for these genes, which contributes to the high number of variable junctions reported (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 3A</xref>). When normalizing the number of variable splice junctions by the number of exons in the canonical transcript annotation of protein-coding genes (MANE or Ensembl Canonical transcripts), we find that genes with high levels of splice junction variation display complex splicing patterns. These variations can involve annotated (e.g. <italic toggle="yes">CMC2</italic>, <italic toggle="yes">ZNF655</italic>) or unannotated (e.g. <italic toggle="yes">UBC</italic>, <italic toggle="yes">MRPL43</italic>) splice junctions (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 3B</xref>).</p>
    </sec>
    <sec id="SEC3-3">
      <title>Tissue-regulated splicing variations in MAJIQlopedia</title>
      <p>We sought to illustrate how the quantifications provided in MAJIQlopedia correspond to the splicing patterns expected from the literature for well-known cases of disease-associated alternative splicing events. In the <italic toggle="yes">WT1</italic> gene, skipping of exon 5 is frequent in Wilms tumor, where a common mutation alters the splice donor downstream of exon 5 (<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>). In line with the literature, MAJIQlopedia shows that Wilms tumor samples have lower exon 5 inclusion levels than other cancer types such as acute myeloid leukemia, mesothelioma or ovarian cancer (Figure <xref rid="F3" ref-type="fig">3A</xref>). In the <italic toggle="yes">MAPT</italic> gene, skipping of exon 10 results in the loss of one of four microtubule-binding sequences and the ratio between exon 10 inclusion and skipping likely impacts neurodegeneration in tauopathies (<xref rid="B44" ref-type="bibr">44–46</xref>). Another alternative splicing event in <italic toggle="yes">MAPT</italic> concerns the inclusion of exon 3, which is associated with Parkinsonian disorders (<xref rid="B47" ref-type="bibr">47</xref>). The inclusion of both of these exons varies by brain region (<xref rid="B48" ref-type="bibr">48</xref>,<xref rid="B49" ref-type="bibr">49</xref>). As expected, MAJIQlopedia shows variable inclusion levels between brain regions for both exon 3 and exon 10 (Figure <xref rid="F3" ref-type="fig">3B</xref>). Intriguingly, <italic toggle="yes">MAPT</italic> exons 3 and 10 are also alternatively used in cancer (Figure <xref rid="F3" ref-type="fig">3B</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Visualization of known tissue-specific alternative splicing variations. (<bold>A</bold>) Inclusion levels of an alternative exon in <italic toggle="yes">WT1</italic> are lower in Wilms tumor samples (TARGET-WT) than in testis or in other cancers (Beat-AML, TCGA-MESO, TCGA-OV). (<bold>B</bold>) Two highly variable alternative exons in <italic toggle="yes">MAPT</italic> have tissue- and cancer-specific usage profiles. (<bold>C</bold>) MAJIQlopedia highlights the neural-specific inclusion of exon 7 (green junction) as well as the muscle-specific inclusion of exon 11 (blue junction) in the <italic toggle="yes">BIN1</italic> gene. Shaded boxes were added to highlight brain tissues (top) and muscle (bottom). Additional splicing variations downstream of exon 12 are detailed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4</xref>. Open boxes between exons represent intron retention events. Quantification panels in (A) and (B) were generated from the data available for download on the home page of MAJIQlopedia, while the quantification panels shown in (C) are screenshots of the MAJIQlopedia website. Boxplots (mostly hidden by violin plots) show 25th and 75th percentiles with whiskers at the 5th and 95th percentiles.</p>
        </caption>
        <graphic xlink:href="gkad1043fig3" position="float"/>
      </fig>
      <p>We also looked into normal tissue-specific splicing patterns. The <italic toggle="yes">BIN1</italic> gene is known for differential inclusion of an exon in neural tissues and a separate exon differentially included in muscle (<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B51" ref-type="bibr">51</xref>). Interrogating MAJIQlopedia for <italic toggle="yes">BIN1</italic> allowed us to quickly appreciate how inclusion of BIN exon 7 is restricted to tissues from the nervous system, whereas inclusion of exon 11 is mostly restricted to muscle (Figure <xref rid="F3" ref-type="fig">3C</xref>). Additional known splicing variations involving exons 14–17 are also represented in the database with complex and highly variable splicing patterns in normal tissues (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4A</xref>). Interestingly, we observed that inclusion of the neural exon 7 and inclusion of the muscle exon 11 also occur in neuroblastoma and head and neck cancer, respectively (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4B</xref>). These results are in line with the fact that, while anatomically distinct from the nervous system, neuroblastoma originates from neural cells (<xref rid="B52" ref-type="bibr">52</xref>). As for the inclusion of exon 11 in head and neck cancer (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 4B</xref>), this event could reflect the tissue of origin of the cancer, since exon 11 is also included in the salivary gland (Figure <xref rid="F3" ref-type="fig">3C</xref>), albeit at lower levels than in muscle.</p>
    </sec>
    <sec id="SEC3-4">
      <title>Discovery of novel splicing variations</title>
      <p>In order to demonstrate the value of MAJIQlopedia for the identification of novel alternative splicing events, we asked whether splicing variations exist in genes for which only one transcript has been annotated in Ensembl (<xref rid="B53" ref-type="bibr">53</xref>), GENCODE (<xref rid="B54" ref-type="bibr">54</xref>) and RefSeq (<xref rid="B55" ref-type="bibr">55</xref>), and no splicing variations were previously reported. We found such variations in multiple genes, including in <italic toggle="yes">FDX1</italic> and <italic toggle="yes">MEGF9</italic>. The mitochondrial ferredoxin gene <italic toggle="yes">FDX1</italic> is involved in the synthesis of steroid hormones. The gene has four exons but only one annotated transcript. PubMed searches return no publications mentioning alternative splicing or the existence of transcript isoforms in <italic toggle="yes">FDX1</italic>. However, MAJIQlopedia shows that a novel 159nt exon between exons 3 and 4 has inclusion levels of 13% specifically in hematopoietic stem cells (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 5A</xref>). MEGF9 is a putative transmembrane receptor that is developmentally regulated. <italic toggle="yes">MEGF9</italic> has 6 exons and, just like <italic toggle="yes">FDX1</italic>, only one annotated transcript and no publication mentions alternative splicing or multiple isoforms for <italic toggle="yes">MEGF9</italic>. We discovered that alpha-beta CD4+ T cells, monocytes and neutrophils use a novel 123nt exon between exons 2 and 3 of <italic toggle="yes">MEGF9</italic> with inclusion levels of 15% (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 5B</xref>).</p>
      <p>In both cases, the novel exons preserve the reading frame but introduce stop codons in the coding sequence. The <italic toggle="yes">FDX1</italic> exon encodes two consecutive stop codons in the penultimate exon. The fate of the <italic toggle="yes">FDX1</italic> transcript that includes the novel exon is uncertain because transcripts with premature stop codons close to the end of the coding sequence, including in the penultimate exons, can escape nonsense mediated decay (<xref rid="B56" ref-type="bibr">56</xref>). If escaping nonsense mediated decay, this transcript would encode an FDX1 protein isoform lacking the last 13 residues of the 2Fe-2S ferredoxin-type domain. On the other hand, the <italic toggle="yes">MEGF9</italic> exon introduces three stop codons several exons upstream of the last exon. It can be expected that the inclusion of the novel MEGF9 exon renders the transcripts sensitive to nonsense-mediated decay. In line with this assumption, we find that neutrophil and monocyte samples that have high inclusion of the novel exon also have lower <italic toggle="yes">MEGF9</italic> transcript levels (Supplementary Figure 5C). The use of NMD-inducing exons, often referred to as ‘poison exons’, is a known mechanism for regulating gene expression (<xref rid="B57" ref-type="bibr">57</xref>). Whether the novel exon is involved in the regulation of MEGF9 levels will require further investigation.</p>
      <p>We also found a novel splicing event in the metallothionein <italic toggle="yes">MT1A</italic> gene, which is involved in metal detoxification and oxidative stress prediction. We observed that alternative skipping of <italic toggle="yes">MT1A</italic> exon 2 is an isoform that co-exists with the only known transcript at variable levels ranging from 10% to 20% in all solid tissues where the variation is quantified (Figure <xref rid="F4" ref-type="fig">4A</xref>). Skipping of exon 2 preserves the reading frame of the coding sequence, but removes 22aa in the beta domain of the protein (Figure <xref rid="F4" ref-type="fig">4B</xref>). The predicted structure for the skipped isoform aligns well with the canonical isoform and shows that the alpha domain is mostly preserved (Figure <xref rid="F4" ref-type="fig">4B</xref>). The loss of the beta domain would reduce the binding capacity of the protein from seven metal atoms to four and prevent the formation of the supermetalated intermediate MT1A species (<xref rid="B58" ref-type="bibr">58</xref>).</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>Novel alternative splicing events highlighted by MAJIQlopedia. (<bold>A</bold>) A novel cassette exon skipping event (blue junctions) in <italic toggle="yes">MT1A</italic> is used in a large array of tissues. (<bold>B</bold>) The <italic toggle="yes">MT1A</italic> skipping event results in the truncation of the beta domain, but preserves the alpha domain. (<bold>C</bold>) A novel exon inclusion event in the <italic toggle="yes">RPS6KA6</italic> is only found in a pediatric high-grade glioma cohort and a pediatric clear cell sarcoma of the kidney cohort. The splicegraphs at the top show that MAJIQlopedia contains no evidence of alternative splicing in normal tissues, but some variations in cancer, most notably the inclusion of a novel exon between exons 2 and 3. (<bold>D</bold>) Raw reads compiled from 13 samples of clear cell sarcoma of the kidney confirming novel exon inclusion. (<bold>E</bold>) Exon 2a inclusion levels compared to total gene expression of RPS6KA6 in high-grade glioma and clear cell sarcoma of the kidney samples.</p>
        </caption>
        <graphic xlink:href="gkad1043fig4" position="float"/>
      </fig>
      <p>Finally, we wondered if MAJIQlopedia contained information about splicing variations that occur in cancer, but not in normal tissues. There are 822 genes that have at least two alternative splice junctions in at least one cancer type, but no alternative junction used over 5% in any normal tissue. One of those genes is the ribosomal kinase <italic toggle="yes">RPS6KA6</italic> gene, which only has one annotated transcript. In agreement with the literature, no splicing variations are observed in normal tissues. However, MAJIQlopedia shows that there is inclusion of a novel exon between exons 2 and 3 of <italic toggle="yes">RPS6KA6</italic> in pediatric cohorts of high-grade glioma and clear cell sarcoma of the kidney at level of 15% and 25%, respectively (Figure <xref rid="F4" ref-type="fig">4C</xref>). Inspection of raw read alignments confirms the inclusion of the novel exon, labeled as ‘exon 2a’ (Figure <xref rid="F4" ref-type="fig">4D</xref>). While exon 2a shifts the reading frame of the coding sequence and introduces several stop codons, there is no clear relationship between the level of exon 2a inclusion and lower transcript levels in the two cancer cohorts that we looked at (Figure <xref rid="F4" ref-type="fig">4E</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="discussion" id="SEC4">
    <title>Discussion</title>
    <p>In this work, we introduce MAJIQlopedia, a new database with a matching webtool, for exploring splicing variations across normal and cancer samples. Using several examples, we illustrate how MAJIQlopedia can be used to analyze known splicing variations as well as a hypothesis generator, identifying novel splicing variations that are tissue or cancer specific. In addition, users can submit requests to add data or install their own private instance with specific data of interest.</p>
    <p>One caveat of MAJIQlopedia is that it does not include developmental tissues. We hope to address this in future updates as new datasets become available. Another limitation is that we are unable to include sample level information. This limitation is due to data access restrictions and not inherent to the tool as both MAJIQ and the visualization package VOILA can display such information. Another future direction to enhance MAJIQlopedia is to incorporate long-reads and full isoform information. It is also important to note that the information provided in MAJIQlopedia, as for all other splicing databases, is not well suited to perform differential splicing analyses between conditions. For such tests users should instead run MAJIQ directly for conditions of interest and consider running MOCCASIN to correct for unknown or known confounders such as batch effects (<xref rid="B59" ref-type="bibr">59</xref>).</p>
    <p>Overall, we believe that MAJIQlopedia, with its unique set of features, supported datasets, and ease of use, will be of great value to the large community of researchers seeking to understand how the expression of their favorite genes might be regulated and those looking to understand tissue- or cancer-specific splice isoform usage.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkad1043_Supplemental_Files</label>
      <media xlink:href="gkad1043_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>Acknowledgements</title>
    <p>We thank early users of MAJIQlopedia from the Thomas-Tikhonenko, Barash and Lynch labs for the feedback they have provided on the webtool.</p>
  </ack>
  <sec sec-type="data-availability" id="SEC5">
    <title>Data availability</title>
    <p>The data underlying MAJIQlopedia is publicly available, with restricted access in some cases, from the sources listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S2 and S3</xref>.</p>
  </sec>
  <sec id="SEC6">
    <title>Supplementary data</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad1043#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>Funding</title>
    <p>Next Generation of Scientists Award from the Cancer Research Society [990633 to M.Q.V.]; U01 and R01 grants from National Institutes of Health [CA232563 to A.T.T., K.W.L. and Y.B.; LM013437 to Y.B.]. Funding for open access charge: NIH [U01 CA232563].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <notes id="NT1">
    <title>Notes</title>
    <p>Present address: Mathieu Quesnel-Vallières, Department of Immunology and Cell Biology, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.</p>
  </notes>
  <ref-list id="REF1">
    <title>References</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Rio</surname><given-names>D.C.</given-names></string-name></person-group><article-title>Mechanisms and regulation of alternative pre-mRNA splicing</article-title>. <source>Annu. Rev. Biochem.</source><year>2015</year>; <volume>84</volume>:<fpage>291</fpage>–<lpage>323</lpage>.<pub-id pub-id-type="pmid">25784052</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gallego-Paez</surname><given-names>L.M.</given-names></string-name>, <string-name><surname>Bordone</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Leote</surname><given-names>A.C.</given-names></string-name>, <string-name><surname>Saraiva-Agostinho</surname><given-names>N.</given-names></string-name>, <string-name><surname>Ascensão-Ferreira</surname><given-names>M.</given-names></string-name>, <string-name><surname>Barbosa-Morais</surname><given-names>N.L.</given-names></string-name></person-group><article-title>Alternative splicing: the pledge, the turn, and the prestige</article-title>. <source>Hum. Genet.</source><year>2017</year>; <volume>136</volume>:<fpage>1015</fpage>–<lpage>1042</lpage>.<pub-id pub-id-type="pmid">28374191</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Barrera</surname><given-names>A.</given-names></string-name>, <string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>González-Vallinas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Hogenesch</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title>. <source>eLife</source>. <year>2016</year>; <volume>5</volume>:<fpage>e11752</fpage>.<pub-id pub-id-type="pmid">26829591</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aguet</surname><given-names>F.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Castel</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>He</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Jo</surname><given-names>B.</given-names></string-name>, <string-name><surname>Mohammadi</surname><given-names>P.</given-names></string-name>, <string-name><surname>Park</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Parsana</surname><given-names>P.</given-names></string-name>, <string-name><surname>Segrè</surname><given-names>A.V.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Genetic effects on gene expression across human tissues</article-title>. <source>Nature</source>. <year>2017</year>; <volume>550</volume>:<fpage>204</fpage>–<lpage>213</lpage>.<pub-id pub-id-type="pmid">29022597</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ule</surname><given-names>J.</given-names></string-name>, <string-name><surname>Blencowe</surname><given-names>B.J.</given-names></string-name></person-group><article-title>Alternative splicing regulatory networks: functions, mechanisms, and evolution</article-title>. <source>Mol. Cell</source>. <year>2019</year>; <volume>76</volume>:<fpage>329</fpage>–<lpage>345</lpage>.<pub-id pub-id-type="pmid">31626751</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>G.-S.</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>T.A.</given-names></string-name></person-group><article-title>Splicing in disease: disruption of the splicing code and the decoding machinery</article-title>. <source>Nat. Rev. Genet.</source><year>2007</year>; <volume>8</volume>:<fpage>749</fpage>–<lpage>761</lpage>.<pub-id pub-id-type="pmid">17726481</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stanley</surname><given-names>R.F.</given-names></string-name>, <string-name><surname>Abdel-Wahab</surname><given-names>O</given-names></string-name></person-group><article-title>Dysregulation and therapeutic targeting of RNA splicing in cancer</article-title>. <source>Nat Cancer</source>. <year>2022</year>; <volume>3</volume>:<fpage>536</fpage>–<lpage>546</lpage>.<pub-id pub-id-type="pmid">35624337</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quesnel-Vallières</surname><given-names>M.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Thomas-Tikhonenko</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>Identifying common transcriptome signatures of cancer by interpreting deep learning models</article-title>. <source>Genome Biol.</source><year>2022</year>; <volume>23</volume>:<fpage>117</fpage>.<pub-id pub-id-type="pmid">35581644</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anczuków</surname><given-names>O.</given-names></string-name>, <string-name><surname>Krainer</surname><given-names>A.R.</given-names></string-name></person-group><article-title>Splicing-factor alterations in cancers</article-title>. <source>RNA</source>. <year>2016</year>; <volume>22</volume>:<fpage>1285</fpage>–<lpage>1301</lpage>.<pub-id pub-id-type="pmid">27530828</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Escobar-Hoyos</surname><given-names>L.</given-names></string-name>, <string-name><surname>Knorr</surname><given-names>K.</given-names></string-name>, <string-name><surname>Abdel-Wahab</surname><given-names>O.</given-names></string-name></person-group><article-title>Aberrant RNA splicing in cancer</article-title>. <source>Annual Review of Cancer Biology</source>. <year>2019</year>; <volume>3</volume>:<fpage>167</fpage>–<lpage>185</lpage>.</mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Consortium</surname><given-names>T.G.T.E.</given-names></string-name>, <string-name><surname>Ardlie</surname><given-names>K.G.</given-names></string-name>, <string-name><surname>Deluca</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Segrè</surname><given-names>A.V.</given-names></string-name>, <string-name><surname>Sullivan</surname><given-names>T.J.</given-names></string-name>, <string-name><surname>Young</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Gelfand</surname><given-names>E.T.</given-names></string-name>, <string-name><surname>Trowbridge</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Maller</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Tukiainen</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title>. <source>Science</source>. <year>2015</year>; <volume>348</volume>:<fpage>648</fpage>–<lpage>660</lpage>.<pub-id pub-id-type="pmid">25954001</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nellore</surname><given-names>A.</given-names></string-name>, <string-name><surname>Jaffe</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Fortin</surname><given-names>J.-P.</given-names></string-name>, <string-name><surname>Alquicira-Hernández</surname><given-names>J.</given-names></string-name>, <string-name><surname>Collado-Torres</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Phillips III</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Karbhari</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hansen</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Langmead</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Human splicing diversity and the extent of unannotated splice junctions across human RNA-seq samples on the Sequence Read Archive</article-title>. <source>Genome Biol.</source><year>2016</year>; <volume>17</volume>:<fpage>266</fpage>.<pub-id pub-id-type="pmid">28038678</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Gaddipati</surname><given-names>P.</given-names></string-name>, <string-name><surname>Nellore</surname><given-names>A.</given-names></string-name>, <string-name><surname>Langmead</surname><given-names>B.</given-names></string-name></person-group><article-title>Snaptron: querying splicing patterns across tens of thousands of RNA-seq samples</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>114</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">28968689</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tapial</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ha</surname><given-names>K.C.H.</given-names></string-name>, <string-name><surname>Sterne-Weiler</surname><given-names>T.</given-names></string-name>, <string-name><surname>Gohr</surname><given-names>A.</given-names></string-name>, <string-name><surname>Braunschweig</surname><given-names>U.</given-names></string-name>, <string-name><surname>Hermoso-Pulido</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quesnel-Vallières</surname><given-names>M.</given-names></string-name>, <string-name><surname>Permanyer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sodaei</surname><given-names>R.</given-names></string-name>, <string-name><surname>Marquez</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms</article-title>. <source>Genome Res.</source><year>2017</year>; <volume>27</volume>:<fpage>1759</fpage>–<lpage>1768</lpage>.<pub-id pub-id-type="pmid">28855263</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>W.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name></person-group><article-title>TSVdb: a web-tool for TCGA splicing variants analysis</article-title>. <source>BMC Genomics</source>. <year>2018</year>; <volume>19</volume>:<fpage>405</fpage>.<pub-id pub-id-type="pmid">29843604</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Meng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Z.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RJunBase: a database of RNA splice junctions in human normal and cancerous tissues</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D201</fpage>–<lpage>D211</lpage>.<pub-id pub-id-type="pmid">33179749</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Tian</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>C.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>50</volume>:<fpage>D1340</fpage>–<lpage>D1347</lpage>.</mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F.Y.</given-names></string-name>, <string-name><surname>Charles</surname><given-names>R.</given-names></string-name>, <string-name><surname>Solomon</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ling</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Imada</surname><given-names>E.L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Joseph</surname><given-names>L.</given-names></string-name>, <string-name><surname>Leek</surname><given-names>J.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>recount3: summaries and queries for large-scale RNA-seq expression and splicing</article-title>. <source>Genome Biol.</source><year>2021</year>; <volume>22</volume>:<fpage>323</fpage>.<pub-id pub-id-type="pmid">34844637</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lang</surname><given-names>K.</given-names></string-name>, <string-name><surname>Jie</surname><given-names>W.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>W.</given-names></string-name></person-group><article-title>MetazExp: a database for gene expression and alternative splicing profiles and their analyses based on 53 615 public RNA-seq samples in 72 metazoan species</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>50</volume>:<fpage>D1046</fpage>–<lpage>D1054</lpage>.</mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zong</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>W.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>P.</given-names></string-name>, <string-name><surname>Li</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>51</volume>:<fpage>D1196</fpage>–<lpage>D1204</lpage>.</mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Aicher</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Jewell</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Radens</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Norton</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>RNA splicing analysis using heterogeneous and large RNA-seq datasets</article-title>. <source>Nat. Commun.</source><year>2023</year>; <volume>14</volume>:<fpage>1230</fpage>.<pub-id pub-id-type="pmid">36869033</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Norton</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>Outlier detection for improved differential splicing quantification from RNA-Seq experiments with replicates</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>1488</fpage>–<lpage>1497</lpage>.<pub-id pub-id-type="pmid">29236961</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mehmood</surname><given-names>A.</given-names></string-name>, <string-name><surname>Laiho</surname><given-names>A.</given-names></string-name>, <string-name><surname>Venäläinen</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>McGlinchey</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>N.</given-names></string-name>, <string-name><surname>Elo</surname><given-names>L.L.</given-names></string-name></person-group><article-title>Systematic evaluation of differential splicing tools for RNA-seq studies</article-title>. <source>Briefings Bioinf.</source><year>2020</year>; <volume>21</volume>:<fpage>2052</fpage>–<lpage>2065</lpage>.</mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lonsdale</surname><given-names>J.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Salvatore</surname><given-names>M.</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lo</surname><given-names>E.</given-names></string-name>, <string-name><surname>Shad</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hasz</surname><given-names>R.</given-names></string-name>, <string-name><surname>Walters</surname><given-names>G.</given-names></string-name>, <string-name><surname>Garcia</surname><given-names>F.</given-names></string-name>, <string-name><surname>Young</surname><given-names>N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Genotype-Tissue Expression (GTEx) project</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>580</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">23715323</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adams</surname><given-names>D.</given-names></string-name>, <string-name><surname>Altucci</surname><given-names>L.</given-names></string-name>, <string-name><surname>Antonarakis</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Ballesteros</surname><given-names>J.</given-names></string-name>, <string-name><surname>Beck</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bird</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bock</surname><given-names>C.</given-names></string-name>, <string-name><surname>Boehm</surname><given-names>B.</given-names></string-name>, <string-name><surname>Campo</surname><given-names>E.</given-names></string-name>, <string-name><surname>Caricasole</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>BLUEPRINT to decode the epigenetic signature written in blood</article-title>. <source>Nat. Biotechnol.</source><year>2012</year>; <volume>30</volume>:<fpage>224</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">22398613</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacRae</surname><given-names>T.</given-names></string-name>, <string-name><surname>Sargeant</surname><given-names>T.</given-names></string-name>, <string-name><surname>Lemieux</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hébert</surname><given-names>J.</given-names></string-name>, <string-name><surname>Deneault</surname><given-names>É.</given-names></string-name>, <string-name><surname>Sauvageau</surname><given-names>G.</given-names></string-name></person-group><article-title>RNA-Seq reveals spliceosome and proteasome genes as most consistent transcripts in human cancer cells</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e72884</fpage>.<pub-id pub-id-type="pmid">24069164</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ranzani</surname><given-names>V.</given-names></string-name>, <string-name><surname>Rossetti</surname><given-names>G.</given-names></string-name>, <string-name><surname>Panzeri</surname><given-names>I.</given-names></string-name>, <string-name><surname>Arrigoni</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bonnal</surname><given-names>R.J.P.</given-names></string-name>, <string-name><surname>Curti</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gruarin</surname><given-names>P.</given-names></string-name>, <string-name><surname>Provasi</surname><given-names>E.</given-names></string-name>, <string-name><surname>Sugliano</surname><given-names>E.</given-names></string-name>, <string-name><surname>Marconi</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4</article-title>. <source>Nat. Immunol.</source><year>2015</year>; <volume>16</volume>:<fpage>318</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">25621826</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scott</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Temiz</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Sarver</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>LaRue</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Rathe</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Varshney</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Moriarity</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>O’Brien</surname><given-names>T.D.</given-names></string-name>, <string-name><surname>Spector</surname><given-names>L.G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Comparative transcriptome analysis quantifies immune cell transcript levels, metastatic progression, and survival in osteosarcoma</article-title>. <source>Cancer Res.</source><year>2018</year>; <volume>78</volume>:<fpage>326</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">29066513</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.-W.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>W.-Y.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>F.-J.</given-names></string-name>, <string-name><surname>Luo</surname><given-names>C.-W.</given-names></string-name></person-group><article-title>Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis</article-title>. <source>Cell Commun. Signal.</source><year>2022</year>; <volume>20</volume>:<fpage>190</fpage>.<pub-id pub-id-type="pmid">36443839</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moriarity</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>Otto</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Rahrmann</surname><given-names>E.P.</given-names></string-name>, <string-name><surname>Rathe</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Weg</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Manlove</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>LaRue</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Temiz</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Molyneux</surname><given-names>S.D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis</article-title>. <source>Nat. Genet.</source><year>2015</year>; <volume>47</volume>:<fpage>615</fpage>–<lpage>624</lpage>.<pub-id pub-id-type="pmid">25961939</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weinstein</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Collisson</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Mills</surname><given-names>G.B.</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>K.R.M.</given-names></string-name>, <string-name><surname>Ozenberger</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Ellrott</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shmulevich</surname><given-names>I.</given-names></string-name>, <string-name><surname>Sander</surname><given-names>C.</given-names></string-name>, <string-name><surname>Stuart</surname><given-names>J.M.</given-names></string-name></person-group><article-title>The Cancer Genome Atlas Pan-Cancer analysis project</article-title>. <source>Nat. Genet.</source><year>2013</year>; <volume>45</volume>:<fpage>1113</fpage>–<lpage>1120</lpage>.<pub-id pub-id-type="pmid">24071849</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname><given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Alexandrov</surname><given-names>L.B.</given-names></string-name>, <string-name><surname>Edmonson</surname><given-names>M.N.</given-names></string-name>, <string-name><surname>Gawad</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Rusch</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Easton</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours</article-title>. <source>Nature</source>. <year>2018</year>; <volume>555</volume>:<fpage>371</fpage>–<lpage>376</lpage>.<pub-id pub-id-type="pmid">29489755</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tyner</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Tognon</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Bottomly</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wilmot</surname><given-names>B.</given-names></string-name>, <string-name><surname>Kurtz</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Savage</surname><given-names>S.L.</given-names></string-name>, <string-name><surname>Long</surname><given-names>N.</given-names></string-name>, <string-name><surname>Schultz</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Traer</surname><given-names>E.</given-names></string-name>, <string-name><surname>Abel</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Functional genomic landscape of acute myeloid leukaemia</article-title>. <source>Nature</source>. <year>2018</year>; <volume>562</volume>:<fpage>526</fpage>–<lpage>531</lpage>.<pub-id pub-id-type="pmid">30333627</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lilly</surname><given-names>J.V.</given-names></string-name>, <string-name><surname>Rokita</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Mason</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Patton</surname><given-names>T.</given-names></string-name>, <string-name><surname>Stefankiewiz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Higgins</surname><given-names>D.</given-names></string-name>, <string-name><surname>Trooskin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Larouci</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Arya</surname><given-names>K.</given-names></string-name>, <string-name><surname>Appert</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science</article-title>. <source>Neoplasia</source>. <year>2022</year>; <volume>35</volume>:<fpage>100846</fpage>.<pub-id pub-id-type="pmid">36335802</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krueger</surname><given-names>F.</given-names></string-name>, <string-name><surname>James</surname><given-names>F.</given-names></string-name>, <string-name><surname>Ewels</surname><given-names>P.</given-names></string-name>, <string-name><surname>Afyounian</surname><given-names>E.</given-names></string-name>, <string-name><surname>Weinstein</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schuster-Boeckler</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hulselmans</surname><given-names>G.</given-names></string-name><collab>sclamons</collab></person-group><article-title>FelixKrueger/TrimGalore: v0.6.10 - add default decompression path</article-title>. <source>Zenodo</source>. <year>2023</year>; <pub-id pub-id-type="doi">10.5281/zenodo.7598955</pub-id>.</mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Schlesinger</surname><given-names>F.</given-names></string-name>, <string-name><surname>Drenkow</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zaleski</surname><given-names>C.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>S.</given-names></string-name>, <string-name><surname>Batut</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chaisson</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gingeras</surname><given-names>T.R.</given-names></string-name></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>15</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hubbard</surname><given-names>T.</given-names></string-name>, <string-name><surname>Barker</surname><given-names>D.</given-names></string-name>, <string-name><surname>Birney</surname><given-names>E.</given-names></string-name>, <string-name><surname>Cameron</surname><given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cox</surname><given-names>T.</given-names></string-name>, <string-name><surname>Cuff</surname><given-names>J.</given-names></string-name>, <string-name><surname>Curwen</surname><given-names>V.</given-names></string-name>, <string-name><surname>Down</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The Ensembl genome database project</article-title>. <source>Nucleic Acids Res.</source><year>2002</year>; <volume>30</volume>:<fpage>38</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">11752248</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>1000 Genome Project Data Processing Subgroup</collab><string-name><surname>Li</surname><given-names>H.</given-names></string-name>, <string-name><surname>Handsaker</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wysoker</surname><given-names>A.</given-names></string-name>, <string-name><surname>Fennell</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ruan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Homer</surname><given-names>N.</given-names></string-name>, <string-name><surname>Marth</surname><given-names>G.</given-names></string-name>, <string-name><surname>Abecasis</surname><given-names>G.</given-names></string-name>, <string-name><surname>Durbin</surname><given-names>R.</given-names></string-name></person-group><article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>2078</fpage>–<lpage>2079</lpage>.<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Patro</surname><given-names>R.</given-names></string-name>, <string-name><surname>Duggal</surname><given-names>G.</given-names></string-name>, <string-name><surname>Love</surname><given-names>M.I.</given-names></string-name>, <string-name><surname>Irizarry</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Kingsford</surname><given-names>C.</given-names></string-name></person-group><article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title>. <source>Nat. Methods</source>. <year>2017</year>; <volume>14</volume>:<fpage>417</fpage>–<lpage>419</lpage>.<pub-id pub-id-type="pmid">28263959</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Akin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Rao</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hie</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>W.</given-names></string-name>, <string-name><surname>Smetanin</surname><given-names>N.</given-names></string-name>, <string-name><surname>Verkuil</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kabeli</surname><given-names>O.</given-names></string-name>, <string-name><surname>Shmueli</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Evolutionary-scale prediction of atomic-level protein structure with a language model</article-title>. <source>Science</source>. <year>2023</year>; <volume>379</volume>:<fpage>1123</fpage>–<lpage>1130</lpage>.<pub-id pub-id-type="pmid">36927031</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berman</surname><given-names>H.M.</given-names></string-name>, <string-name><surname>Westbrook</surname><given-names>J.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Gilliland</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bhat</surname><given-names>T.N.</given-names></string-name>, <string-name><surname>Weissig</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shindyalov</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Bourne</surname><given-names>P.E.</given-names></string-name></person-group><article-title>The Protein Data Bank</article-title>. <source>Nucleic Acids Res.</source><year>2000</year>; <volume>28</volume>:<fpage>235</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Simms</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>Algar</surname><given-names>E.M.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>P.J.</given-names></string-name></person-group><article-title>Splicing of exon 5 in the WT1 gene is disrupted in Wilms’ tumour</article-title>. <source>Eur. J. Cancer</source>. <year>1995</year>; <volume>31</volume>:<fpage>2270</fpage>–<lpage>2276</lpage>.</mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schneider</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wildhardt</surname><given-names>G.</given-names></string-name>, <string-name><surname>Ludwig</surname><given-names>R.</given-names></string-name>, <string-name><surname>Royer-Pokora</surname><given-names>B.</given-names></string-name></person-group><article-title>Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms’ tumor and severe genital malformations</article-title>. <source>Hum. Genet.</source><year>1993</year>; <volume>91</volume>:<fpage>599</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="pmid">8393425</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hernández</surname><given-names>F.</given-names></string-name>, <string-name><surname>Pérez</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lucas</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Mata</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Bhat</surname><given-names>R.</given-names></string-name>, <string-name><surname>Avila</surname><given-names>J.</given-names></string-name></person-group><article-title>Glycogen synthase kinase-3 plays a crucial role in Tau exon 10 splicing and intranuclear distribution of SC35: implications for Alzheimer's disease</article-title>. <source>J. Biol. Chem.</source><year>2004</year>; <volume>279</volume>:<fpage>3801</fpage>–<lpage>3806</lpage>.<pub-id pub-id-type="pmid">14602710</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name></person-group><article-title>Alternative splicing: human disease and quantitative analysis from high-throughput sequencing</article-title>. <source>Comput. Struct. Biotechnol. J.</source><year>2020</year>; <volume>19</volume>:<fpage>183</fpage>–<lpage>195</lpage>.<pub-id pub-id-type="pmid">33425250</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>F.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>C.-X.</given-names></string-name></person-group><article-title>Tau exon 10 alternative splicing and tauopathies</article-title>. <source>Mol. Neurodegener.</source><year>2008</year>; <volume>3</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">18616804</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lai</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Bechy</surname><given-names>A.-L.</given-names></string-name>, <string-name><surname>Denk</surname><given-names>F.</given-names></string-name>, <string-name><surname>Collins</surname><given-names>E.</given-names></string-name>, <string-name><surname>Gavriliouk</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zaugg</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Ryan</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Wade-Martins</surname><given-names>R.</given-names></string-name>, <string-name><surname>Caffrey</surname><given-names>T.M.</given-names></string-name></person-group><article-title>Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders</article-title>. <source>Mol.r Neurodegener.</source><year>2017</year>; <volume>12</volume>:<fpage>79</fpage>.</mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trabzuni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wray</surname><given-names>S.</given-names></string-name>, <string-name><surname>Vandrovcova</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ramasamy</surname><given-names>A.</given-names></string-name>, <string-name><surname>Walker</surname><given-names>R.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>C.</given-names></string-name>, <string-name><surname>Luk</surname><given-names>C.</given-names></string-name>, <string-name><surname>Gibbs</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Dillman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hernandez</surname><given-names>D.G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies</article-title>. <source>Hum. Mol. Genet.</source><year>2012</year>; <volume>21</volume>:<fpage>4094</fpage>–<lpage>4103</lpage>.<pub-id pub-id-type="pmid">22723018</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corsi</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bombieri</surname><given-names>C.</given-names></string-name>, <string-name><surname>Valenti</surname><given-names>M.T.</given-names></string-name>, <string-name><surname>Romanelli</surname><given-names>M.G.</given-names></string-name></person-group><article-title>Tau Isoforms: gaining Insight into MAPT Alternative Splicing</article-title>. <source>Int. J. Mol. Sci.</source><year>2022</year>; <volume>23</volume>:<fpage>15383</fpage>.<pub-id pub-id-type="pmid">36499709</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gazzara</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Vaquero-Garcia</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>In silico to in vivo splicing analysis using splicing code models</article-title>. <source>Methods</source>. <year>2014</year>; <volume>67</volume>:<fpage>3</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">24321485</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Nagel</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Fagg</surname><given-names>W.S.</given-names></string-name>, <string-name><surname>Shiue</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cline</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Perriman</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Donohue</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Ares</surname><given-names>M.</given-names></string-name></person-group><article-title>Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation</article-title>. <source>RNA</source>. <year>2013</year>; <volume>19</volume>:<fpage>627</fpage>–<lpage>638</lpage>.<pub-id pub-id-type="pmid">23525800</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnsen</surname><given-names>J.I.</given-names></string-name>, <string-name><surname>Dyberg</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wickström</surname><given-names>M.</given-names></string-name></person-group><article-title>Neuroblastoma—a neural crest derived embryonal malignancy</article-title>. <source>Front. Mol. Neurosci.</source><year>2019</year>; <volume>12</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">30760980</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cunningham</surname><given-names>F.</given-names></string-name>, <string-name><surname>Allen</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Allen</surname><given-names>J.</given-names></string-name>, <string-name><surname>Alvarez-Jarreta</surname><given-names>J.</given-names></string-name>, <string-name><surname>Amode</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Armean</surname><given-names>I.M.</given-names></string-name>, <string-name><surname>Austine-Orimoloye</surname><given-names>O.</given-names></string-name>, <string-name><surname>Azov</surname><given-names>A.G.</given-names></string-name>, <string-name><surname>Barnes</surname><given-names>I.</given-names></string-name>, <string-name><surname>Bennett</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Ensembl 2022</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D988</fpage>–<lpage>D995</lpage>.<pub-id pub-id-type="pmid">34791404</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frankish</surname><given-names>A.</given-names></string-name>, <string-name><surname>Diekhans</surname><given-names>M.</given-names></string-name>, <string-name><surname>Jungreis</surname><given-names>I.</given-names></string-name>, <string-name><surname>Lagarde</surname><given-names>J.</given-names></string-name>, <string-name><surname>Loveland</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Mudge</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Sisu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Armstrong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Barnes</surname><given-names>I.</given-names></string-name><etal>et al</etal>.</person-group><article-title>GENCODE 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D916</fpage>–<lpage>D923</lpage>.<pub-id pub-id-type="pmid">33270111</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>O’Leary</surname><given-names>N.A.</given-names></string-name>, <string-name><surname>Wright</surname><given-names>M.W.</given-names></string-name>, <string-name><surname>Brister</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Ciufo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Haddad</surname><given-names>D.</given-names></string-name>, <string-name><surname>McVeigh</surname><given-names>R.</given-names></string-name>, <string-name><surname>Rajput</surname><given-names>B.</given-names></string-name>, <string-name><surname>Robbertse</surname><given-names>B.</given-names></string-name>, <string-name><surname>Smith-White</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ako-Adjei</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D733</fpage>–<lpage>D745</lpage>.<pub-id pub-id-type="pmid">26553804</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Supek</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lehner</surname><given-names>B.</given-names></string-name>, <string-name><surname>Lindeboom</surname><given-names>R.G.H.</given-names></string-name></person-group><article-title>To NMD or not to NMD: nonsense-mediated mRNA decay in cancer and other genetic diseases</article-title>. <source>Trends Genet.</source><year>2021</year>; <volume>37</volume>:<fpage>657</fpage>–<lpage>668</lpage>.<pub-id pub-id-type="pmid">33277042</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leclair</surname><given-names>N.K.</given-names></string-name>, <string-name><surname>Brugiolo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Urbanski</surname><given-names>L.</given-names></string-name>, <string-name><surname>Lawson</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Thakar</surname><given-names>K.</given-names></string-name>, <string-name><surname>Yurieva</surname><given-names>M.</given-names></string-name>, <string-name><surname>George</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hinson</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>A.</given-names></string-name>, <string-name><surname>Graveley</surname><given-names>B.R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Poison exon splicing regulates a coordinated network of SR protein expression during differentiation and tumorigenesis</article-title>. <source>Mol. Cell</source>. <year>2020</year>; <volume>80</volume>:<fpage>648</fpage>–<lpage>665</lpage>.<pub-id pub-id-type="pmid">33176162</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sutherland</surname><given-names>D.E.K.</given-names></string-name>, <string-name><surname>Willans</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Stillman</surname><given-names>M.J.</given-names></string-name></person-group><article-title>Single domain metallothioneins: supermetalation of human MT 1a</article-title>. <source>J. Am. Chem. Soc.</source><year>2012</year>; <volume>134</volume>:<fpage>3290</fpage>–<lpage>3299</lpage>.<pub-id pub-id-type="pmid">22242602</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Slaff</surname><given-names>B.</given-names></string-name>, <string-name><surname>Radens</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Jewell</surname><given-names>P.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lahens</surname><given-names>N.F.</given-names></string-name>, <string-name><surname>Grant</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Thomas-Tikhonenko</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Barash</surname><given-names>Y.</given-names></string-name></person-group><article-title>MOCCASIN: a method for correcting for known and unknown confounders in RNA splicing analysis</article-title>. <source>Nat. Commun.</source><year>2021</year>; <volume>12</volume>:<fpage>3353</fpage>.<pub-id pub-id-type="pmid">34099673</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
